Malignant neoplasm of endocrine gland

C3_ENDOCRINE

endocrine neoplasm: A benign or malignant neoplasm arising from the epithelial cells of an endocrine organ. Representative examples include pituitary gland adenoma, pituitary gland carcinoma, thyroid gland carcinoma, carcinoid tumor, and neuroendocrine carcinoma.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints C3_THYROID_GLAND C3_ADRENAL_GLAND C3_ENDOCRINE_NAS	3312
6. Filter based on genotype QC (FinnGen only)	3022

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF4

NAME	C3_ENDOCRINE
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	C3_THYROID_GLAND\|C3_ADRENAL_GLAND\|C3_ENDOCRINE_NAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of endocrine gland based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3022	2183	839
Unadjusted period prevalence (%)	0.67	0.78	0.38
Median age at first event (years)	52.23	49.59	59.11

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3126: Matched controls
31260

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

56.9

307.7

232

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

97.2

307.7

820

114

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

29.5

307.7

709

308

C73.92

ICD-10 Finland

Follicular carcinoma of the thyroid gland

3750.8

307.7

346

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

443

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

100.7

307.7

207

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

148.1

307.7

853

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

307.7

2267

EP1AE

NOMESCO Finland

Neck ultrasound examination

47.0

307.7

1534

628

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

307.7

2151

106

Kela drug reimbursment

Hypoparathyroidism

80.0

307.7

181

ZX114

NOMESCO Finland

Intramuscular

46.7

307.7

467

117

H02AB02

ATC

dexamethasone; systemic

22.5

307.7

342

170

4CJ01, ,

NOMESCO Finland

+∞

307.7

308

H03AA01

ATC

levothyroxine sodium; systemic

44.6

307.7

2822

5384

BAA60

NOMESCO Finland

Total thyroidectomy

122.2

307.7

1635

278

A11CC03

ATC

alfacalcidol; systemic

15.9

307.7

316

220

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

+∞

307.7

460

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

+∞

307.7

360

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

5.5

307.7

1879

6739

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

23.4

307.7

345

165

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

78.5

307.7

226

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

+∞

307.7

364

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

10.0

307.7

493

574

A04AA02

ATC

granisetron; systemic, transdermal

166.6

307.7

188

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

35.3

307.7

439

144

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

+∞

307.7

386

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

77.6

307.7

1052

203

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

307.7

700

104

Kela drug reimbursment

Thyroid insufficiency

51.7

307.7

2125

1233

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

145.2

304.2

152

E89.09

ICD-10 Finland

Postprocedural hypothyroidism, other or several procedures

82.0

293.7

156

WF002

NOMESCO Finland

Radical radiotherapy

59.0

280.3

157

BA1NN

NOMESCO Finland

I-131 dose capsel measurement

+∞

253.7

240

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

+∞

247.2

234

8330/3-C73.9

ICD-O-3

Follicular carcinoma, NOS, of thyroid gland

+∞

247.2

234

1930A

ICD-9 Finland

Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]

+∞

237.6

225

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

43.1

233.8

140

E04.1

ICD-10 Finland

Nontoxic single thyroid nodule

11.7

233.5

247

228

115

Kela drug reimbursment

Breast cancer

+∞

233.3

221

WX402

NOMESCO Finland

General anaesthesia

3.6

231.7

1051

3838

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

12.1

230.3

238

212

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

83.9

228.4

121

PJA12

NOMESCO Finland

Sentinel node biopsy

542.9

207.4

204

Z51.88

ICD-10 Finland

Other specified medical care

10.6

205.2

231

233

WX408

NOMESCO Finland

General anesthesy, balanced

3.3

202.4

1096

4413

T71

ICPC

Malignant neoplasm thyroid

+∞

202.3

192

XX3DW

NOMESCO Finland

Time consuming IT work

6.3

202.2

365

641

D34

ICD-10 Finland

Benign neoplasm of thyroid gland

23.0

201.0

147

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

18.8

186.7

149

E83.51

ICD-10 Finland

Hypocalcemia

24.2

181.6

130

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

8.1

179.9

252

336

WZC00

NOMESCO Finland

Treatment plan or consultation

2.9

178.3

1398

6836

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

15.7

176.0

154

103

EP1DG

NOMESCO Finland

Very extensive examination of soft tissue of neck with high intesity magnet

26.5

173.6

120

2506

FHL

Thyroidectomy

293.2

164.4

166

JN4BD

NOMESCO Finland

Extensive body CT

6.0

162.1

302

544

WF049

NOMESCO Finland

Radiotherapy of metastasis

556.0

161.5

159

A11CC02

ATC

dihydrotachysterol; oral

40.0

159.2

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

8.1

157.4

219

289

WX404

NOMESCO Finland

Intravenous generell anesthesy

3.1

155.0

844

3339

19399

ICD-8 Finland

Malignant neoplasm of thyroid gland

+∞

154.5

147

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

5.9

149.2

283

518

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

149.2

142

8341/3-C73.9

ICD-O-3

Papillary microcarcinoma of thyroid gland

+∞

146.0

139

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

741.9

145.2

142

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

143.9

137

JN4AD

NOMESCO Finland

Body CT examination

4.7

141.2

351

814

ZXE10

NOMESCO Finland

More than one and less than three hours

2.6

140.9

1348

7083

A03FA01

ATC

metoclopramide; systemic, rectal

3.2

138.8

691

2579

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

137.5

131

BCA31

NOMESCO Finland

Endoscopic unilateral adrenalectomy

28.7

137.0

JN6AD

NOMESCO Finland

CT of torso and neck

20.9

135.7

103

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

24.1

134.3

A12AA04

ATC

calcium carbonate; oral

11.1

131.3

141

132

HAB40

NOMESCO Finland

Wedge excision of mammary gland

17.6

126.8

104

EP2AT

NOMESCO Finland

Neck soft tissue cytology with ultrasound guidance

49.8

126.0

ZXE20

NOMESCO Finland

More than three and less than five hours

3.4

124.6

532

1802

Z51.5

ICD-10 Finland

Palliative care

5.9

123.2

233

424

C61

ICD-10 Finland

Malignant neoplasm of prostate

627.3

123.1

121

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

118.5

113

L03AA13

ATC

pegfilgrastim; parenteral

594.8

116.8

115

TPH07

NOMESCO Finland

Cathetrisation of artery

3.5

116.8

451

1431

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

116.4

111

8340/3-C73.9

ICD-O-3

Papillary carcinoma, follicular variant of thyroid gland

+∞

115.3

110

WF003

NOMESCO Finland

Adjuvant radiotherapy

584.0

114.7

113

L02BG04

ATC

letrozole; oral

8.2

113.3

154

197

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

109.0

104

C739, ,

ICD-10 Finland

+∞

107.9

103

WZC30

NOMESCO Finland

Teaching

2.9

107.6

584

2262

GD6AD

NOMESCO Finland

CT of chest and neck

33.1

105.9

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

4.9

103.9

239

517

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

1042.2

103.9

101

A04AA01

ATC

ondansetron; systemic, rectal

5.0

103.6

235

502

HA1AA

NOMESCO Finland

X-ray mammography

4.7

101.7

250

571

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

58.0

101.3

UDQ12

NOMESCO Finland

Flexible laryngoscopy

3.8

98.1

325

927

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

+∞

94.2

2505

FHL

Bilateral resection (also used if total removal has been performed on the other side)

16.0

94.2

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

935.8

93.4

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

244.8

93.1

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.8

92.8

219

483

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

144.5

92.6

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

92.1

BBA70

NOMESCO Finland

Implantation or transplantation of parathyroid gland

33.4

92.1

E03.89

ICD-10 Finland

Other specified hypothyroidism

4.0

91.8

274

725

T86

ICPC

Hypothyroidism/myxoedema

3.8

91.7

305

871

HAC20

NOMESCO Finland

Total mastectomy

126.4

91.5

L02BA01

ATC

tamoxifen; oral

126.4

91.5

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

236.9

90.0

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

9.2

83.4

102

114

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

829.9

82.9

PJD91

NOMESCO Finland

Excision of lymph nodes in neck, 1 to 2 areas in total

829.9

82.9

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

22.6

82.0

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

21.4

81.5

NK6AN

NOMESCO Finland

Total body bone isotope imaging

29.9

80.0

A04AA55

ATC

palonosetron, combinations; systemic

+∞

79.5

GD1AD

NOMESCO Finland

Thorax CT examination

3.8

79.1

255

711

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

787.8

78.7

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

46.7

78.1

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

11.1

76.7

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

34.8

75.8

WX704

NOMESCO Finland

Intubation

3.0

73.4

348

1236

JN4CD

NOMESCO Finland

Very extensive body CT

8.3

73.2

120

BBA30

NOMESCO Finland

Excision of lesion of parathyroid gland

7.3

71.7

106

149

116

Kela drug reimbursment

Prostate cancer

+∞

71.1

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

703.8

70.3

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

703.8

70.3

ZXD10

NOMESCO Finland

Scheduled procedure

2.0

70.2

1247

7858

C73.94

ICD-10 Finland

Medullary thyroid carcinoma (thyroid)

+∞

70.1

C50.99

ICD-10 Finland

Breast, unspecified

242.1

69.6

WF004

NOMESCO Finland

Palliative radiotherapy

693.3

69.3

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

69.0

C74.0

ICD-10 Finland

Malignant neoplasm: Cortex of adrenal gland

+∞

69.0

WW200

NOMESCO Finland

Immunization

5.1

68.0

148

304

L01BC06

ATC

capecitabine; oral

+∞

66.9

EP1AE, ,

SPAT

4.7

65.2

154

339

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

8.6

63.6

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

9.6

63.5

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

62.7

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

24.8

62.2

ZXE30

NOMESCO Finland

More than five and less than seven hours

4.2

62.0

170

421

C74.1

ICD-10 Finland

Malignant neoplasm: Medulla of adrenal gland

+∞

61.7

L03AA02

ATC

filgrastim; parenteral

96.3

60.1

WX302

NOMESCO Finland

Thoracal epidural anesthesy

4.8

59.8

139

302

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.9

59.3

180

480

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.2

58.7

575

2879

H02AB09

ATC

hydrocortisone; systemic

4.9

58.0

129

270

JN5SN, ,

NOMESCO Finland

+∞

57.5

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

57.1

1447

10033

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

568.2

56.8

ZX070

NOMESCO Finland

Intensity modified radiotherapy

150.3

56.0

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

71.3

55.3

E04.0

ICD-10 Finland

Nontoxic diffuse goitre

7.8

54.9

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

547.4

54.7

ZX090

NOMESCO Finland

Other technic of radiotherapy

87.4

54.0

Z31.5

ICD-10 Finland

Genetic counselling

3.4

53.7

207

647

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

275.7

53.3

ZXA10

NOMESCO Finland

Bilateral

2.1

52.9

639

3457

E27.5

ICD-10 Finland

Adrenomedullary hyperfunction

270.3

52.3

8290/3-C73.9

ICD-O-3

Oxyphilic adenocarcinoma of thyroid gland

+∞

52.2

C74.9

ICD-10 Finland

Malignant neoplasm: Adrenal gland, unspecified

+∞

52.2

XW000

NOMESCO Finland

Bone marrow biopsy

5.0

50.7

111

229

N02AA05

ATC

oxycodone; systemic

2.2

50.7

475

2325

A12AA06

ATC

calcium lactate gluconate; oral

81.5

50.1

DQE10

NOMESCO Finland

Injection of foreign material into vocal cord

15.6

49.5

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

254.1

49.2

XX1MN

NOMESCO Finland

Isotope examination with measurement

+∞

49.1

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

49.1

C73.93

ICD-10 Finland

Anaplastic thyroid carcinoma (thyroid)

+∞

48.0

PJA10

NOMESCO Finland

Exploration of lymph nodes

12.2

47.1

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

47.0

B01AB10

ATC

tinzaparin; parenteral

2.5

47.0

326

1398

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

7.9

46.9

Z85.8

ICD-10 Finland

Personal history of malignant neoplasms of other organs and systems

+∞

45.9

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

45.9

B01AB05

ATC

enoxaparin; parenteral

1.8

45.5

910

5780

BAA99

NOMESCO Finland

Other operation on thyroid gland

159.0

44.9

C50

ICD-10 Finland

Malignant neoplasm of breast

159.0

44.9

8700/3-C74.1

ICD-O-3

Pheochromocytoma, NOS, of medulla of adrenal gland

+∞

44.9

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

4.1

44.8

124

309

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

44.6

664

3839

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

4.8

44.5

101

215

A79

ICPC

Malignancy NOS

443.9

44.3

ZXA05

NOMESCO Finland

Left side

1.9

43.9

731

4381

WW500

NOMESCO Finland

Blood transfusion

4.9

43.8

202

Y77

ICPC

Malignant neoplasm prostate

433.6

43.3

ZX080

NOMESCO Finland

Image guided radiotherapy

223.1

43.0

8700/3-C74.9

ICD-O-3

Pheochromocytoma, NOS, of adrenal gland, NOS

+∞

42.8

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

42.8

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

8.2

42.3

BCA30

NOMESCO Finland

Unilateral adrenalectomy

93.4

41.9

ZSB00

NOMESCO Finland

Procedure related to previous procedure classified in chapter B

55.3

41.5

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

40.7

198

Kela drug reimbursment

Sorafenib

+∞

40.7

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

59.6

40.3

BAA20

NOMESCO Finland

Unilateral partial excision of thyroid gland

13.9

39.9

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

39.7

JN5AN

NOMESCO Finland

Total body isotope imaging

+∞

39.7

2504

FHL

Unilateral resection or enucleation

7.6

39.5

XX2RW, ,

NOMESCO Finland

7.4

39.4

ZXE00

NOMESCO Finland

One hour or less

1.7

39.2

1170

8238

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

392.3

39.1

3019

Kela drug reimbursment

Lenvatinib

+∞

38.6

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

11.2

38.0

A04AD12

ATC

aprepitant; systemic

135.0

37.8

WVA30

NOMESCO Finland

Intramuscular and subcutaneous injection

12.0

37.7

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

4.8

37.7

184

1508

Kela drug reimbursment

Lenvatinib

+∞

37.6

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

37.6

8345/3-C73.9

ICD-O-3

Medullary thyroid carcinoma of thyroid gland

+∞

37.6

WX725

NOMESCO Finland

Noninvasive ventilation

2.7

37.3

210

811

N02BE01

ATC

paracetamol; systemic, rectal

2.1

37.2

2804

25080

PJD51

NOMESCO Finland

Block dissection of cervical lymph nodes

371.7

37.1

L02AE02

ATC

leuprorelin; implant, parenteral

5.7

37.1

123

8370/3-C74.0

ICD-O-3

Adrenal cortical carcinoma of cortex of adrenal gland

+∞

36.5

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

5.4

36.2

133

BA1AQ

NOMESCO Finland

Thyroid SPECT with low dose CT

187.2

35.8

X76

ICPC

Malignant neoplasm breast female

128.2

35.8

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

4.3

35.5

218

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

182.0

34.8

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

34.4

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

34.4

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

34.4

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

4.5

34.1

187

C75.0

ICD-10 Finland

Malignant neoplasm: Parathyroid gland

340.8

34.0

E03

ICD-10 Finland

Other hypothyroidism

2.3

33.9

262

1175

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

33.4

8510/3-C73.9

ICD-O-3

Medullary carcinoma, NOS, of thyroid gland

+∞

33.4

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

56.4

33.3

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

32.3

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

32.3

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

3.1

31.9

139

467

E83.50

ICD-10 Finland

Hypercalcemia

5.2

31.6

127

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

31.3

L01EX08

ATC

lenvatinib; oral

+∞

31.3

L01XX23

ATC

mitotane; oral

+∞

31.3

L02BG03

ATC

anastrozole; oral

60.7

31.1

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

70.6

30.9

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.5

30.7

195

799

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.6

30.3

181

720

323

Kela drug reimbursment

Sorafenib

+∞

30.3

S18

ICPC

Laceration/cut

1.5

30.1

1377

10542

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

305.3

29.8

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

83.4

29.8

A06AH03

ATC

naloxegol; oral

9.1

29.5

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

29.2

8020/3-C73.9

ICD-O-3

Carcinoma, undifferentiated, NOS, of thyroid gland

+∞

29.2

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.6

29.2

179

721

TQW20

NOMESCO Finland

Tatoe

57.3

29.1

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

6.0

29.0

L02BG06

ATC

exemestane; oral

294.6

28.8

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

7.4

28.4

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

26.3

28.4

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

28.2

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

55.6

28.2

H03BB01

ATC

carbimazole; oral

2.6

28.1

172

692

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

64.6

27.9

ZXA00

NOMESCO Finland

Right side

1.6

27.9

741

4982

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

284.0

27.8

PJD99

NOMESCO Finland

Excision of other lymph nodes

146.3

27.7

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

35.4

27.4

XX9XW, ,

NOMESCO Finland

7.2

27.1

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

27.1

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

27.1

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

28.0

26.7

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

26.1

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

26.1

L02BB03

ATC

bicalutamide; oral

+∞

26.1

8000/3-C73.9

ICD-O-3

Neoplasm, malignant of thyroid gland

+∞

26.1

E8901, C7391,

ICD-10 Finland

+∞

26.1

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

60.5

26.0

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.4

25.6

187

816

BB1BQ

NOMESCO Finland

Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT

7.9

25.5

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.7

25.3

141

542

WZC15, ,

NOMESCO Finland

22.7

25.2

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.0

25.1

180

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

4.4

25.1

146

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

5.2

25.0

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

9.2

24.7

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

131.1

24.6

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

7.3

24.6

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

24.4

356

2017

SPAT1153

SPAT

Removal of sutures

1.5

24.1

861

6172

ZX050

NOMESCO Finland

Stereotactic radiotherapy

56.5

24.0

EP1BG

NOMESCO Finland

MRI examination of soft tissue of neck with high intesity magnet

8.5

24.0

ZX112

NOMESCO Finland

Subcutaneous

5.9

24.0

8010/3-C75.0

ICD-O-3

Carcinoma, NOS, of parathyroid gland

+∞

24.0

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

6.1

23.7

HAB99

NOMESCO Finland

Other partial excision of mammary gland

5.1

23.7

100

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

23.8

23.5

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

23.4

452

2781

E21.0

ICD-10 Finland

Primary hyperparathyroidism

3.3

23.4

276

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

2.0

23.2

283

1509

BA2AT

NOMESCO Finland

Biopsy of thyroid with ultrasound quidance

28.4

23.1

WA039

NOMESCO Finland

Radiotherapy with free isotopes

+∞

22.9

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

22.9

BWD00

NOMESCO Finland

Reoperation for deep haemorrhage in endocrine surgery

40.4

22.7

E05.2

ICD-10 Finland

Thyrotoxicosis with toxic multinodular goitre

4.0

22.6

158

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

22.4

714

4975

R49.08

ICD-10 Finland

Other specified dysphonia

3.0

22.1

333

E20.8

ICD-10 Finland

Other hypoparathyroidism

52.4

22.1

L01XE05

ATC

[U] sorafenib

+∞

21.9

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

21.9

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

21.9

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

21.9

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

21.9

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

21.9

1930B

ICD-9 Finland

Malignant neoplasm of thyroid gland[CARCINOMA FOLLICULARE THYREOIDEAE]

+∞

21.9

Z51.0

ICD-10 Finland

Radiotherapy session

80.7

21.7

R49.01

ICD-10 Finland

Functional dysphonia

2.6

21.6

127

501

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

221.5

21.6

BA1AE, ,

SPAT

3.8

21.4

178

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

21.4

259

1377

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.1

21.1

223

1129

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.0

21.1

236

1220

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

2.7

20.9

112

422

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

+∞

20.9

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

20.9

1930X

ICD-9 Finland

Malignant neoplasm of thyroid gland[NEOPLASMA MALIGNUM THYREOIDEAE EI HISTOL VAHV]

+∞

20.9

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

20.9

3025

Kela drug reimbursment

Calcium carbonate

7.1

20.8

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.4

20.6

226

GD6BD

NOMESCO Finland

Extensive CT of chest and neck

30.2

20.5

GBB00

NOMESCO Finland

Tracheostomy

5.5

20.5

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

8.2

20.5

R13

ICD-10 Finland

Dysphagia

2.0

20.5

232

1205

24199

ICD-8 Finland

Non-toxic nodular goitre, Unspecified

4.7

20.3

102

JDB10

NOMESCO Finland

Percutaneous gastrostomy

6.2

20.2

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

48.3

20.2

R4130

NOMESCO Finland

Speech therapy

2.9

20.1

335

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

6.6

20.0

ZX120

NOMESCO Finland

Intravenous

2.1

20.0

199

986

J01DB01

ATC

cefalexin; oral

1.5

19.8

2473

22278

L01AX03

ATC

temozolomide; systemic

+∞

19.8

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

19.8

1AB01, ,

NOMESCO Finland

+∞

19.8

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

19.8

BA2MN

NOMESCO Finland

Thyroid radiation dose measurement during isotope therapy

+∞

19.8

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

19.8

C90.0

ICD-10 Finland

Multiple myeloma

+∞

19.8

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

19.8

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

105.7

19.6

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

19.5

ZXC96

NOMESCO Finland

Robot assisted procedure

5.7

19.4

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

22.7

19.0

Z50.5

ICD-10 Finland

Speech therapy

3.9

18.8

143

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

18.8

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

18.8

8010/3-C73.9

ICD-O-3

Carcinoma, NOS, of thyroid gland

+∞

18.8

UJC01

NOMESCO Finland

Scopy of lower throat

5.4

18.5

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

4.7

18.4

KAC10

NOMESCO Finland

Total nephrectomy with capsule

30.2

18.3

E21.3

ICD-10 Finland

Hyperparathyroidism, unspecified

3.8

18.3

146

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

44.3

18.2

E20.9

ICD-10 Finland

Hypoparathyroidism, unspecified

21.8

18.2

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.6

18.0

171

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.8

18.0

322

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

52.8

18.0

QX4AT

NOMESCO Finland

Ultrsound guided needle biopsy of skin

13.8

17.7

EP1DM

NOMESCO Finland

Very extensive MRI examination of soft tissue of neck with 3 Tesla magnet

67.0

17.7

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

17.7

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

17.7

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

17.7

XX1XN

NOMESCO Finland

Other isotope examination

+∞

17.7

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

36.9

17.6

WX720

NOMESCO Finland

Own respiration

2.2

17.5

159

760

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

181.0

17.5

E04.8

ICD-10 Finland

Other specified nontoxic goitre

6.6

17.5

D25.1

ICD-10 Finland

Intramural leiomyoma of uterus

2.0

17.4

206

1086

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

7.8

17.4

R50.9

ICD-10 Finland

Fever, unspecified

1.7

17.3

381

2417

WX400

NOMESCO Finland

Inhalation anesthesy

2.3

17.1

128

565

D11.0

ICD-10 Finland

Benign neoplasm: Parotid gland

3.4

17.1

177

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

12.6

17.1

L01XX05

ATC

hydroxycarbamide; oral

31.6

17.0

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

50.3

17.0

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

17.0

173

865

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

16.9

2113

18672

R4110

NOMESCO Finland

Physiotherapy

1.5

16.9

717

5265

BAA30

NOMESCO Finland

Excision of thyroid isthmus

19.4

16.9

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

16.7

291

1732

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

16.7

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

16.7

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

16.7

9500/3-C74.1

ICD-O-3

Neuroblastoma, NOS, of medulla of adrenal gland

+∞

16.7

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

16.7

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

16.7

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

16.7

RL210, ,

NOMESCO Finland

6.5

16.6

XKD00

NOMESCO Finland

Uroflowmetry

1.8

16.6

273

1598

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

6.7

16.6

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

90.6

16.6

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.4

16.5

181

EP1CM

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with 3 Tesla magnet

27.7

16.5

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

23.2

16.4

D25.9

ICD-10 Finland

Leiomyoma of uterus, unspecified

1.7

16.3

289

1730

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.4

16.1

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.8

16.0

236

1337

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.2

16.0

132

608

E07.9

ICD-10 Finland

Disorder of thyroid, unspecified

6.2

15.9

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

4.5

15.9

Z3226

NOMESCO Finland

Physiotherapist

1.5

15.7

476

3254

ZZF00

NOMESCO Finland

Graft of adipose tissue

6.9

15.7

2419X

ICD-9 Finland

Non-toxic nodular goitre, Unspecified non-toxic nodular goitre

6.9

15.7

H02AA02

ATC

fludrocortisone; oral

4.8

15.6

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

15.6

L01CA04

ATC

vinorelbine; systemic

+∞

15.6

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

15.6

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

15.6

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

15.6

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

15.6

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

15.6

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

+∞

15.6

YX9AW, ,

NOMESCO Finland

85.5

15.6

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

85.5

15.6

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

85.5

15.6

KCD02

NOMESCO Finland

Transurethral resection of bladder

11.3

15.2

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

2.0

15.2

172

894

4701

FHL

Neck lymph node removal

23.5

15.1

UJF32

NOMESCO Finland

Coloscopy

1.4

15.1

680

5037

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.6

15.1

133

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

15.1

229

1309

A02BC02

ATC

pantoprazole; systemic

1.4

15.0

1977

17428

UDQ02

NOMESCO Finland

Direct laryngoscopy

4.6

14.9

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

56.9

14.8

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

16.5

14.7

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

3.4

14.6

155

L01EX02

ATC

sorafenib; oral

+∞

14.6

L02BX02

ATC

degarelix; parenteral

+∞

14.6

8680/3-C75.5

ICD-O-3

Paraganglioma, NOS, of aortic body and other paraganglia

+∞

14.6

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

14.6

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

14.6

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

+∞

14.6

XX1AD

NOMESCO Finland

Other CT-examination

80.5

14.6

128

Kela drug reimbursment

Cancers of female genital organs

80.5

14.6

H01CB03

ATC

lanreotide; parenteral

150.7

14.5

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

150.7

14.5

J01MA12

ATC

levofloxacin; systemic

1.5

14.4

441

3019

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

15.4

14.4

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.2

14.3

183

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

4.7

14.2

ZZR00

NOMESCO Finland

Flap of skin

5.7

14.1

T73

ICPC

Neoplasm endocrine other/unspecified

42.7

14.1

2410A

ICD-9 Finland

Non-toxic nodular goitre, Non-toxic uninodular goitre

12.0

14.1

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

6.7

14.0

D70.82

ICD-10 Finland

Drug-induced neutropenia

10.1

13.9

BBA20

NOMESCO Finland

Exploration of parathyroid gland

10.1

13.9

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

3.0

13.9

212

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

2.1

13.9

126

603

M05BX04

ATC

denosumab; parenteral

2.0

13.9

157

815

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

30.2

13.9

BC1AD

NOMESCO Finland

CT of adrenal glands

3.9

13.8

104

S04

ICPC

Lump/swelling localized

1.6

13.7

319

2048

BC1CD

NOMESCO Finland

Very extensive CT of adrenal glands

6.5

13.6

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

75.5

13.6

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

75.5

13.6

T85

ICPC

Hyperthyroidism/thyrotoxicosis

4.3

13.6

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

13.5

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

13.5

8335/3-C73.9

ICD-O-3

Follicular carcinoma, minimally invasive of thyroid gland

+∞

13.5

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

+∞

13.5

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

13.5

L01XE29

ATC

[U] lenvatinib

+∞

13.5

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

+∞

13.5

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

13.5

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

13.5

1172

9645

T81

ICPC

Goitre

5.5

13.5

B01AB04

ATC

dalteparin; parenteral

2.1

13.5

128

624

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

140.6

13.5

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

140.6

13.5

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.5

13.4

349

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.8

13.4

200

1138

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

13.4

194

1094

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

18.3

13.4

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

40.2

13.1

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

13.1

562

4111

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.1

12.9

173

2260A

ICD-9 Finland

Benign neoplasm of thyroid gland[NEOPLASMA BENIGNUM GLANDULAE THYREOIDEAE]

13.0

12.9

N63

ICD-10 Finland

Unspecified lump in breast

1.8

12.5

178

997

L02BA03

ATC

fulvestrant; parenteral

+∞

12.5

YA1CD

NOMESCO Finland

Very extensive CT examination of head and neck for dose design of radiotherapy

+∞

12.5

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

+∞

12.5

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

12.5

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

12.5

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

12.5

C82.1

ICD-10 Finland

Follicular lymphoma grade II

130.5

12.4

Z2221

NOMESCO Finland

Medical doctor

1.4

12.3

715

5513

D44.8

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement

37.7

12.2

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

3.4

12.0

129

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.6

12.0

277

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

11.9

769

6029

E04

ICD-10 Finland

Other nontoxic goitre

5.9

11.8

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.6

11.8

256

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

2.0

11.7

131

678

UDC00

NOMESCO Finland

Ear microscopy

1.7

11.7

202

1199

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

3.1

11.7

157

ZZR10

NOMESCO Finland

Flap of skin and muscle

16.5

11.7

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

3.5

11.7

117

D48.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other specified sites

4.6

11.6

HAE99

NOMESCO Finland

Other reconstruction of breast

12.6

11.6

Z3231

NOMESCO Finland

Registered nurse

1.4

11.6

662

5084

S77

ICPC

Malignant neoplasm of skin

19.0

11.6

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

23.0

11.6

ZYC06

NOMESCO Finland

Real-time text-based remote transaction

9.3

11.5

153

Kela drug reimbursment

Lenalidomid

+∞

11.5

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

11.5

L01CB01

ATC

etoposide; systemic

+∞

11.5

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

+∞

11.5

1CD02, ,

NOMESCO Finland

+∞

11.5

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

11.5

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

+∞

11.5

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

+∞

11.5

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

11.5

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

11.5

YNB10

NOMESCO Finland

Collection of stem cells for transplant

+∞

11.5

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

11.5

L04AX04

ATC

lenalidomide; oral

+∞

11.5

BC5AQ

NOMESCO Finland

Chromaffine tissue SPECT with low dose CT

+∞

11.5

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

11.5

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

120.5

11.4

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

120.5

11.4

WW300

NOMESCO Finland

Transfer of autologic stem cells

120.5

11.4

D44.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Endocrine gland, unspecified

120.5

11.4

L02AE03

ATC

goserelin; implant

4.5

11.4

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

11.4

372

2577

C08CA01

ATC

amlodipine; oral

1.3

11.3

1030

8482

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

11.3

311

2076

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.7

11.2

210

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

5.6

11.2

LCA06

NOMESCO Finland

Biopsy of endometrium

1.5

11.1

358

2470

2397A

ICD-9 Finland

Neoplasm of unspecified nature, Endocrine glands and other parts of nervous system

25.1

11.1

N02AA01

ATC

morphine; systemic, rectal

3.7

11.1

J37.0

ICD-10 Finland

Chronic laryngitis

2.1

11.1

102

492

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

11.1

808

6442

ENB50

NOMESCO Finland

Excision of cyst or fistula of thyroglossic duct

11.2

11.0

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

5.4

10.9

ZXB10

NOMESCO Finland

Medial

5.4

10.9

ELB40

NOMESCO Finland

Partial parotidectomy

3.5

10.9

103

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

10.8

1465

12697

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.6

10.8

232

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

2.5

10.7

268

GAB20

NOMESCO Finland

Median sternotomy

28.1

10.7

EP1AT

NOMESCO Finland

Punction of soft tissue of neck with ultrasound guidance

17.9

10.7

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

60.2

10.6

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

14.2

10.5

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

10.5

173

1015

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

110.4

10.4

D35.59

ICD-10 Finland

Other paragangliom

110.4

10.4

E89.1

ICD-10 Finland

Postprocedural hypoinsulinaemia

110.4

10.4

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

10.4

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

10.4

329

Kela drug reimbursment

Lenalidomide

+∞

10.4

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

+∞

10.4

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

10.4

8339/3-C73.9

ICD-O-3

Follicular carcinoma, encapsulated, angioinvasive of thyroid gland

+∞

10.4

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

10.4

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

10.4

197

Kela drug reimbursment

Sunitinib

+∞

10.4

2411A

ICD-9 Finland

Non-toxic nodular goitre, Non-toxic multinodular goitre

5.4

10.4

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.6

10.4

225

XJH00

NOMESCO Finland

Transanal ultrasonography

2.1

10.3

433

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

10.3

218

1368

XQ846

NOMESCO Finland

Digital dermatoscopy and registration of nevi

23.4

10.2

HA1HA

NOMESCO Finland

Tomosynthesis mammography

13.1

10.1

BAA50

NOMESCO Finland

Lobectomy and resection of contralateral lobe of thyroid gland

13.1

10.1

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

10.1

229

1459

TKE00

NOMESCO Finland

Needle biopsy of prostate

3.2

10.1

118

J01MA02

ATC

ciprofloxacin; systemic

1.3

10.1

981

8121

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

5.3

10.1

R4190

NOMESCO Finland

Nutritional therapy

2.1

10.0

444

Q18.0

ICD-10 Finland

Sinus, fistula and cyst of branchial cleft

5.2

9.8

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

9.8

176

1058

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

9.7

208

1309

E89.0

ICD-10 Finland

Postprocedural hypothyroidism

13.4

9.7

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

55.2

9.6

E05

ICD-10 Finland

Thyrotoxicosis [hyperthyroidism]

3.1

9.6

127

FM1FN

NOMESCO Finland

Heart function isotope examination

100.3

9.4

JN7AQ

NOMESCO Finland

Somatostatin receptor SPET med low dose CT

100.3

9.4

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

17.6

9.4

GB1AA

NOMESCO Finland

Tracheal X-ray examination

17.6

9.4

L02BB04

ATC

enzalutamide; oral

+∞

9.4

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

9.4

XX7JT

NOMESCO Finland

Somatostatin isotope ablative therapy

+∞

9.4

C79.0

ICD-10 Finland

Secondary malignant neoplasm of kidney and renal pelvis

+∞

9.4

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

9.4

C75

ICD-10 Finland

Malignant neoplasm of other endocrine glands and related structures

+∞

9.4

394

Kela drug reimbursment

Palbociclib

+∞

9.4

C92.1

ICD-10 Finland

Chronic myeloid leukaemia [CML], BCR/ABL-positive

+∞

9.4

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

9.4

JN5FN

NOMESCO Finland

Scintigraphy of thyroid metastases in connection with ablation

+∞

9.4

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

9.4

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

9.4

L01XE01

ATC

[U] imatinib

+∞

9.4

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

9.4

D09.3

ICD-10 Finland

Carcinoma in situ: Thyroid and other endocrine glands

+∞

9.4

189

Kela drug reimbursment

Imatinib

+∞

9.4

C75.9

ICD-10 Finland

Malignant neoplasm: Endocrine gland, unspecified

+∞

9.4

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

9.4

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

8.0

9.3

R07.0

ICD-10 Finland

Pain in throat

1.6

9.3

206

1308

E26.0

ICD-10 Finland

Primary hyperaldosteronism

4.1

9.2

JN5JR

NOMESCO Finland

Extensive PET-CT of upper body metabolism (eyebrows to thighs)

13.7

9.2

D45

ICD-10 Finland

Polycythaemia vera

13.7

9.2

-1, ,

ICD-10 Finland

1.8

9.1

129

723

D48.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Breast

2.8

9.1

164

H05BX01

ATC

cinacalcet; oral

4.3

9.1

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

3.6

9.1

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

4.8

9.1

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

36.8

9.0

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

36.8

9.0

BA3AT, ,

SPAT

10.0

9.0

321

Kela drug reimbursment

Paricalcitol and cinacalcet

4.1

9.0

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.2

9.0

311

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

8.9

1671

14920

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.8

8.9

155

UGB02

NOMESCO Finland

Tracheoscopy

12.6

8.9

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

12.6

8.9

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

8.0

8.8

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.1

8.7

360

UDQ22

NOMESCO Finland

Microlaryngoscopy

4.1

8.7

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

50.1

8.7

PJ4AT

NOMESCO Finland

Labeling lymphnode with ultrasound guidance

50.1

8.7

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

7.6

8.6

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.6

8.6

187

N02AX02

ATC

tramadol; systemic, rectal

1.3

8.6

1113

9513

HAD99

NOMESCO Finland

Other plastic operation on breast

8.2

8.6

205

Kela drug reimbursment

Chronic hypertension

1.3

8.5

612

4848

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

20.1

8.5

DQE20

NOMESCO Finland

Implantation of foreign material in vocal chord

20.1

8.5

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

90.3

8.4

WX1CG

NOMESCO Finland

Extensive total body MRI with high intensity magnet

90.3

8.4

N05CF01

ATC

zopiclone; oral

1.3

8.4

813

6700

WX734

NOMESCO Finland

JET-ventilation

12.8

8.4

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

3.4

8.3

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

8.3

L01EA01

ATC

imatinib; oral

+∞

8.3

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

+∞

8.3

C20

ICD-10 Finland

Malignant neoplasm of rectum

+∞

8.3

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

+∞

8.3

C07.70

ICD-10 Finland

Malignant tumor of the superficial part of the parotid gland

+∞

8.3

C76.0

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Head, face and neck

+∞

8.3

C50.2

ICD-10 Finland

Malignant neoplasm: Upper-inner quadrant of breast

+∞

8.3

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

8.3

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

8.3

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

+∞

8.3

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

8.3

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

8.3

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

8.3

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

8.3

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

+∞

8.3

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

8.3

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

+∞

8.3

8344/3-C73.9

ICD-O-3

Papillary carcinoma, columnar cell of thyroid gland

+∞

8.3

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

8.3

1501

Kela drug reimbursment

Palbociclib

+∞

8.3

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

+∞

8.3

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

8.3

794

6529

WX892

NOMESCO Finland

Monitored bed care

1.6

8.3

173

1082

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

7.1

8.2

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

7.5

8.1

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

4.8

8.1

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

2.7

8.1

152

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.9

8.1

517

2533

FHL

Unilateral removal of additional egg

33.4

8.1

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

33.4

8.1

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

2.0

8.1

392

QA4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in face

8.9

8.0

B03XA02

ATC

darbepoetin alfa; parenteral

2.9

8.0

125

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

4.1

8.0

C07AA05

ATC

propranolol; systemic

1.3

8.0

558

4398

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

7.9

2692

25645

Z43.0

ICD-10 Finland

Attention to tracheostomy

13.0

7.9

TQW40, ,

SPAT

1.5

7.8

253

1750

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.0

7.8

111

E20

ICD-10 Finland

Hypoparathyroidism

45.1

7.7

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.6

7.7

168

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

2.6

7.7

168

XX3AT

NOMESCO Finland

Other labeling with ultrasound guidance

18.4

7.6

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.9

7.5

509

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

2.7

7.5

147

DHB00

NOMESCO Finland

Excision of lesion of external nose

7.1

7.5

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

7.1

7.5

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

2.4

7.4

213

D30.0

ICD-10 Finland

Benign neoplasm: Kidney

3.1

7.4

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

3.9

7.4

23914

ICD-8 Finland

Neoplasm of unspecified nature of other and unspecified organs, Glandulae thyreoideae

80.3

7.4

JJB71

NOMESCO Finland

Laparoscopic resection of liver

80.3

7.4

P01AB01

ATC

metronidazole; oral, rectal

1.2

7.4

1119

9689

EL4AT

NOMESCO Finland

Salivary gland cytology with ultrasound guidance

6.5

7.4

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

2.8

7.4

131

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

3.0

7.3

104

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.5

7.3

178

8370/3-C74.9

ICD-O-3

Adrenal cortical carcinoma of adrenal gland, NOS

+∞

7.3

JJB10

NOMESCO Finland

Atypcal resection of liver

+∞

7.3

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

7.3

C64.80

ICD-10 Finland

Wilms tumour

+∞

7.3

CKE60

NOMESCO Finland

Brachytherapy of choroid and retina

+∞

7.3

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

7.3

192

Kela drug reimbursment

Fulvestrant

+∞

7.3

C24.9

ICD-10 Finland

Malignant neoplasm: Biliary tract, unspecified

+∞

7.3

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

7.3

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

+∞

7.3

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

7.3

322

Kela drug reimbursment

Sunitinib

+∞

7.3

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

7.3

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

+∞

7.3

BC5AN

NOMESCO Finland

Chromaffine and adrenergic tissue isotope imaging (MIBG)

+∞

7.3

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

7.3

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

7.3

M49.5*C79.5

ICD-10 Finland

Metastatic fracture of vertebra

+∞

7.3

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

7.3

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

7.3

9680/3-C73.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of thyroid gland

+∞

7.3

L01EF01

ATC

palbociclib; oral

+∞

7.3

8010/3-C74.9

ICD-O-3

Carcinoma, NOS, of adrenal gland, NOS

+∞

7.3

3012

Kela drug reimbursment

Cabozantinib

+∞

7.3

TKE10

NOMESCO Finland

Puncture of prostate

+∞

7.3

CKE65

NOMESCO Finland

Removal of brachytherapeutic plate from eye

+∞

7.3

8021/3-C73.9

ICD-O-3

Carcinoma, anaplastic, NOS, of thyroid gland

+∞

7.3

XX7HT

NOMESCO Finland

Chromaffine tissue (MIBG) isotope therapy

+∞

7.3

L01EX07

ATC

cabozantinib; oral

+∞

7.3

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

+∞

7.3

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

+∞

7.3

C69.30

ICD-10 Finland

Malignant tumor of the chorioidea without histology

+∞

7.3

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

7.3

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

+∞

7.3

2374A

ICD-9 Finland

Neoplasm of uncertain behaviour of endocrine glands and nervous system, Other and unspecified endocrine glands

+∞

7.3

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

+∞

7.3

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

7.3

1930D

ICD-9 Finland

Malignant neoplasm of thyroid gland[CARCINOMA MEDULLARE THYREOIDEAE]

+∞

7.3

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

+∞

7.3

8272/3-C75.1

ICD-O-3

Pituitary carcinoma, NOS, of pituitary gland

+∞

7.3

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

7.3

KAD01

NOMESCO Finland

Percutaneous endoscopic partial nephrectomy

10.9

7.3

E05.4

ICD-10 Finland

Thyrotoxicosis factitia

10.9

7.3

R11

ICD-10 Finland

Nausea and vomiting

1.5

7.3

220

1499

R21

ICPC

Throat symptom/complaint

1.3

7.3

568

4541

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

2.8

7.2

127

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.4

7.2

198

H02AB06

ATC

prednisolone; systemic

1.2

7.2

1271

11182

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

7.3

7.2

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

7.2

970

8291

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

30.1

7.1

2509

FHL

Other measure in this category

20.1

7.1

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

20.1

7.1

GDC00

NOMESCO Finland

Lobectomy of lung

20.1

7.1

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.0

7.1

342

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

7.1

713

5884

D22.3

ICD-10 Finland

Melanocytic naevi of other and unspecified parts of face

2.1

7.1

289

DWD00

NOMESCO Finland

Reoperation for superficial heamorrhage in surgery of ear, nose and larynx

12.0

7.1

ZX121

NOMESCO Finland

Central venous catheter

12.0

7.1

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

12.0

7.1

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

7.1

121

720

WF099

NOMESCO Finland

Other radiotherapy

10.0

7.0

TPX15

NOMESCO Finland

Removal of vascular injection port

10.0

7.0

UJC12

NOMESCO Finland

Flexible oesophagoscopy

3.6

7.0

HAB00

NOMESCO Finland

Excision of lesion of mammary gland

2.2

7.0

277

E03.2

ICD-10 Finland

Hypothyroidism due to medicaments and other exogenous substances

4.2

7.0

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

2.9

7.0

107

LCB25

NOMESCO Finland

Hysteroscopic excision of lesion

1.6

7.0

137

845

R04.2

ICD-10 Finland

Haemoptysis

2.0

7.0

393

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

3.3

7.0

A02BC05

ATC

esomeprazole; systemic

1.2

7.0

1117

9719

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

2.9

6.9

108

E06.3

ICD-10 Finland

Autoimmune thyroiditis

3.1

6.9

R06.0

ICD-10 Finland

Dyspnoea

1.3

6.8

713

5911

ELB50

NOMESCO Finland

Total parotidectomy

9.3

6.8

KAD00

NOMESCO Finland

Partial nephrectomy

9.3

6.8

L02AE04

ATC

triptorelin; parenteral

40.1

6.8

E24.9

ICD-10 Finland

Cushing syndrome, unspecified

16.7

6.7

EWE00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of teeth, jaws, mouth and pharynx

16.7

6.7

GEB30

NOMESCO Finland

Mediastinotomy and excision of lesion

16.7

6.7

WX002

NOMESCO Finland

Sedation and analgesia

1.3

6.7

459

3598

L91.0

ICD-10 Finland

Hypertrophic scar

2.7

6.7

132

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

7.2

6.7

A01AB09

ATC

miconazole; local oral

1.5

6.7

210

1443

K11.2

ICD-10 Finland

Sialoadenitis

1.8

6.7

514

D44.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Parathyroid gland

22.6

6.7

OAA41

NOMESCO Finland

Health check based on individual needs

22.6

6.7

UKC02

NOMESCO Finland

Cystoscopy

1.4

6.7

298

2187

E05.80

ICD-10 Finland

Subacute thyrotoxicosis

2.7

6.6

122

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.5

6.6

157

KAC00

NOMESCO Finland

Nephrectomy

12.3

6.6

R01AD09

ATC

mometasone; nasal

1.2

6.6

1293

11467

J01FA10

ATC

azithromycin; systemic

1.2

6.6

1628

14770

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

10.0

6.5

RP210, ,

NOMESCO Finland

10.0

6.5

KAC11

NOMESCO Finland

Total nephrectomy with capsule, transcutaneous

10.0

6.5

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

2.1

6.5

292

C03CA01

ATC

furosemide; systemic

1.3

6.5

646

5318

TQW99

NOMESCO Finland

Other minor procedure on skin

1.9

6.5

454

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.5

6.5

215

1495

T72

ICPC

Benign neoplasm thyroid

5.7

6.4

XF600

NOMESCO Finland

Bloodpressure measurement

1.6

6.4

140

887

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

70.0

6.4

V04CD01

ATC

metyrapone; oral

70.0

6.4

D47.3

ICD-10 Finland

Essential (haemorrhagic) thrombocythaemia

70.0

6.4

R86.0

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of enzymes

3.2

6.4

HA1SA

NOMESCO Finland

Expansion mammography

14.3

6.4

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

14.3

6.4

R49.09

ICD-10 Finland

Unspecified dysphonia

2.6

6.4

142

R31

ICD-10 Finland

Unspecified haematuria

1.5

6.3

184

1244

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

6.3

990

8569

KED22

NOMESCO Finland

Transurethral resection of prostate

1.9

6.3

414

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

6.5

6.3

101

Kela drug reimbursment

Anterior pituitary hypofunction

3.5

6.3

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

9.3

6.3

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

6.3

331

H01CB02

ATC

octreotide; parenteral

18.0

6.3

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

18.0

6.3

2502

FHL

Thyroid exploration and possible biopsy

18.0

6.3

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

18.0

6.3

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

+∞

6.3

4707

FHL

Dissection Colli radicalis

+∞

6.3

JN5AP

NOMESCO Finland

Total body PET (1 picture)

+∞

6.3

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

6.3

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

6.3

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

6.3

1930A, ,

ICD-10 Finland

+∞

6.3

3054, ,

Kela drug reimbursment

+∞

6.3

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

+∞

6.3

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

6.3

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

6.3

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

+∞

6.3

HAC25

NOMESCO Finland

Radical mastectomy

+∞

6.3

C73, C75,

ICD-10 Finland

+∞

6.3

9962/3-C42.1

ICD-O-3

Essential thrombocythemia of bone marrow

+∞

6.3

C43.79

ICD-10 Finland

Malignant melanoma of the lower extremity including hip or other unspecified histology

+∞

6.3

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

6.3

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

6.3

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

6.3

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

+∞

6.3

XX2ET, ,

NOMESCO Finland

+∞

6.3

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

6.3

5639

FHL

Other measure in this category

+∞

6.3

L01EX01

ATC

sunitinib; oral

+∞

6.3

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

6.3

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

6.3

C43.53

ICD-10 Finland

Malignant melanoma of the torso nodular

+∞

6.3

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

+∞

6.3

8140/3-C75.0

ICD-O-3

Adenocarcinoma, NOS, of parathyroid gland

+∞

6.3

8317/3-C64.9

ICD-O-3

Renal cell carcinoma, chromophobe type of kidney, NOS

+∞

6.3

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

6.3

C50.1

ICD-10 Finland

Malignant neoplasm: Central portion of breast

+∞

6.3

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

+∞

6.3

1523, ,

Kela drug reimbursment

+∞

6.3

WW402

NOMESCO Finland

Leucoferesis

+∞

6.3

L03AB05

ATC

interferon alfa-2b; parenteral

+∞

6.3

ZSP00

NOMESCO Finland

Procedure related to previous procedure classified in chapter P

26.7

6.2

ZSH00

NOMESCO Finland

Procedure related to previous procedure classified in chapter H

26.7

6.2

GBB13

NOMESCO Finland

Revision of tracheostomy

26.7

6.2

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

7.0

6.2

Q18.8

ICD-10 Finland

Other specified congenital malformations of face and neck

7.0

6.2

G04CA02

ATC

tamsulosin; oral

1.3

6.2

363

2784

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

3.5

6.2

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.7

6.1

112

680

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

6.1

268

1962

D75

ICPC

Malignant neoplasm colon/rectum

12.5

6.1

D17.1

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

1.8

6.0

457

J02AC01

ATC

fluconazole; systemic

1.2

6.0

1152

10164

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(4035726) Immunohistochemistry procedure

781

795

12.76

307.65

1.5

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

2092

132

477.11

307.65

8.9

1.1

46.01

127.65

u/ml

0.80

859

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1858

1872

23.00

307.65

8.0

3.2

4.50

4.51

pmol/l

0.12

1814

1665

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

2085

2606.75

307.65

8.4

1.2

68.39

51.05

ug/l

0.29

1330

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2378

11548

5.43

307.65

11.5

5.8

1.20

1.22

mmol/l

27.88

2307

10515

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2571

13053

6.46

307.65

13.9

6.2

1.20

1.22

mmol/l

41.58

2256

11251

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

947

2136

5.93

307.65

3.6

3.8

52.88

85.66

ng/l

34.90

852

1841

(3018418) pH of Serum or Plasma

1943

7707

5.02

307.65

8.8

3.4

7.40

0.35

1567

5439

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

766

384

26.10

307.65

1.6

1.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1764

8809

3.30

232.61

4.9

2.1

2.30

2.36

mmol/l

41.38

1665

7826

(3002256) Pathology report gross observation

747

2385

3.80

198.39

1.5

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1947

11514

2.83

169.11

3.0

2.4

—

estimate

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2962

22484

7.05

168.43

13.2

4.6

17.60

14.69

pmol/l

307.65

2888

20815

(40768804) Tissue Pathology biopsy report

1715

9613

2.74

163.69

2.5

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

1449

7697

2.65

150.53

2.5

2.0

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

903

3817

2.92

146.12

4.2

2.8

0.81

0.83

mmol/l

2.53

871

3545

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

444

1221

4.07

143.04

4.6

1.5

17.75

2.57

ug/l

0.89

338

917

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

537

1945

3.13

111.71

7.7

3.0

1.21

1.23

mmol/l

11.39

502

1609

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

207

371

5.90

111.04

3.4

1.2

1.78

0.19

nmol/l

0.76

163

292

(3024561) Albumin [Mass/volume] in Serum or Plasma

1764

11289

2.29

109.42

6.2

4.0

36.39

36.38

g/l

0.02

1690

10483

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1975

13262

2.33

108.99

3.3

2.5

78.41

78.20

nmol/l

0.13

1881

12004

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1086

5829

2.32

100.70

2.5

2.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

217

445

5.17

100.32

3.6

1.3

0.39

0.40

nmol/l

0.02

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1899

12892

2.21

97.05

8.1

4.0

10.89

11.18

umol/l

0.41

1832

12124

(3010838) Calcium [Moles/time] in 24 hour Urine

227

530

4.54

89.65

2.4

2.1

5.78

5.26

mmol/24h

1.06

212

465

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

962

5138

2.26

88.12

4.3

2.1

2.40

2.44

mmol/l

11.14

885

4540

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2575

20229

2.55

87.40

11.0

5.9

76.99

76.13

u/l

0.61

2498

18980

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

185

373

5.21

87.05

3.4

1.3

—

nmol/l

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

683

3183

2.47

85.31

6.3

5.7

1.08

1.04

mmol/l

2.53

639

2926

(3013650) Neutrophils [#/volume] in Blood by Automated count

2031

14599

2.12

83.70

11.2

7.0

3.93

4.13

e9/l

4.14

1773

12530

(40768795) Lymph node Pathology biopsy report

15.33

82.05

1.3

1.0

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2985

26017

4.27

71.41

17.2

5.6

1.55

1.88

mu/l

1.83

2891

24312

(3013826) Glucose [Moles/volume] in Serum or Plasma

2056

15490

1.96

66.15

6.1

4.6

6.49

6.61

mmol/l

2.36

1980

14549

(3011985) Renin [Units/volume] in Plasma

169

413

4.27

62.68

2.6

1.4

58.60

62.65

mu/l

0.08

153

373

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

22.22

62.35

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

260

891

3.09

57.95

2.5

2.1

3.68

9.93

iu/l

0.51

138

379

(3033658) Prothrombin time (PT) actual/Normal

1008

6260

1.90

56.43

4.3

3.6

94.71

92.12

3.20

993

6099

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

217

690

3.30

54.76

2.3

1.8

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

533

2662

2.21

54.41

3.7

1.9

387.57

369.32

nmol/l

0.51

508

2443

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

149

391

3.95

50.13

1.4

1.3

275.64

343.15

pmol/l

2.05

129

341

(3032080) INR in Blood by Coagulation assay

1565

11401

1.75

49.69

12.2

14.4

1.16

1.23

inr

6.86

1306

9442

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

441

2132

2.24

48.38

5.7

2.5

235.55

228.31

u/l

0.76

421

1993

(40768793) Breast Pathology biopsy report

111

257

4.44

44.09

1.3

1.2

—

(3027801) Oxygen [Partial pressure] in Arterial blood

495

2641

2.04

41.66

7.4

8.3

13.04

11.88

kpa

5.03

475

2536

(3019977) pH of Arterial blood

495

2642

2.04

41.62

7.5

8.3

7.42

0.39

258

1490

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

495

2642

2.04

41.62

7.4

8.3

5.17

5.08

kpa

1.60

475

2536

(3003396) Base excess in Arterial blood by calculation

490

2615

2.04

41.18

7.4

8.3

0.98

1.13

mmol/l

0.38

416

2141

(3003694) ABO and Rh group [Type] in Blood

1052

7153

1.71

40.51

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

155

490

3.28

39.37

3.2

2.1

254.47

24.75

u/ml

0.83

133

395

(3023368) Bacteria identified in Blood by Culture

923

6113

1.72

38.79

4.8

3.8

—

(3016502) Oxygen saturation in Arterial blood

444

2340

2.05

38.45

7.5

8.7

96.30

95.31

3.24

429

2256

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

455

2426

2.02

38.14

3.7

3.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

287

1275

2.38

38.01

8.8

11.2

16.54

16.02

2.31

278

1225

(3002173) Hemoglobin [Mass/volume] in Arterial blood

410

2169

2.02

34.94

8.0

9.1

123.66

122.10

g/l

0.81

400

2116

(3002030) Lymphocytes/Leukocytes in Blood

1632

12766

1.58

33.86

7.4

6.1

27.69

28.72

3.27

1563

12043

(3019069) Monocytes/Leukocytes in Blood

1596

12435

1.58

33.57

7.5

6.2

8.68

8.66

0.08

1519

11601

(3006504) Eosinophils/Leukocytes in Blood

1593

12415

1.58

33.40

7.4

6.1

2.80

2.93

1.16

1518

11573

(3042111) Morphology [Interpretation] in Bone marrow Narrative

179

4.50

32.27

1.5

1.2

—

(3022096) Basophils/Leukocytes in Blood

1588

12433

1.56

32.15

7.5

6.2

0.68

0.70

0.62

1511

11564

(1617658) Protocol used for examination of sentinel lymph nodes

+∞

31.30

1.0

0.0

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

379

2024

1.99

31.28

2.0

2.2

0.23

0.21

g/l

3.83

360

1867

(3045142) Bone marrow Pathology biopsy report

5.89

30.08

1.5

1.2

—

(3019198) Lymphocytes [#/volume] in Blood

1739

14015

1.54

30.04

7.2

6.1

1.91

e9/l

0.03

1555

12338

(3012565) Volume of 24 hour Urine

115

5.30

29.84

2.8

2.0

1911.89

1959.23

0.13

101

(3019550) Sodium [Moles/volume] in Serum or Plasma

2966

27536

2.51

29.45

23.3

15.5

139.85

139.81

mmol/l

0.41

2933

26977

(3001604) Monocytes [#/volume] in Blood

1700

13688

1.53

29.08

7.2

6.0

0.57

e9/l

0.17

1475

11757

(3006315) Basophils [#/volume] in Blood

1704

13732

1.53

29.00

7.2

6.0

0.04

e9/l

0.71

1479

11794

(3013115) Eosinophils [#/volume] in Blood

1752

14204

1.53

28.98

7.5

6.2

0.19

0.20

e9/l

0.88

1554

12421

(3018010) Neutrophils/Leukocytes in Blood

1576

12569

1.51

27.61

7.3

6.0

57.65

56.76

2.36

1525

11967

(3023103) Potassium [Moles/volume] in Serum or Plasma

2964

27601

2.43

27.58

23.7

15.6

3.91

3.96

mmol/l

18.78

2922

26984

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

148

4.53

27.34

1.4

4.17

4.65

umol/l

0.37

133

(40758558) Short blood count panel - Blood

1067

7884

1.54

26.49

7.0

4.6

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

102

331

3.15

24.85

1.3

1.2

—

34.44

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2897

26878

2.06

24.80

20.7

13.1

21.20

21.47

mg/l

0.19

2523

21514

(3047181) Lactate [Moles/volume] in Blood

171

731

2.42

24.55

5.2

6.6

1.25

1.27

mmol/l

0.11

150

638

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2529

22672

1.60

23.12

27.0

15.9

13.58

13.48

3.43

2512

22332

(3020911) Cortisol [Moles/time] in 24 hour Urine

103

4.92

22.95

1.7

1.5

296.19

69.22

nmol/24h

1.65

103

(3039000) Anion gap in Blood by calculation

124

473

2.69

22.56

5.8

8.3

11.01

11.46

mmol/l

0.64

115

420

(3018572) Chloride [Moles/volume] in Blood

124

474

2.68

22.47

5.8

8.3

105.75

104.87

mmol/l

1.83

115

421

(3042936) Bacteria identified in Isolate by Culture

522

3382

1.65

22.17

2.1

2.0

—

(3021589) Normoblasts [#/volume] in Blood

1485

12045

1.44

21.83

15.8

9.6

0.00

e9/l

0.11

1230

9837

(3002582) Erythrocytes [#/volume] in Urine

1083

8303

1.47

21.32

3.4

3.2

43.25

63.93

e6/l

0.83

848

6233

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

1168

9092

1.45

21.20

3.5

3.2

—

1.64

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

19.81

1.1

0.0

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

263

1444

1.90

19.72

6.3

7.0

25.00

24.61

mmol/l

1.10

250

1379

(3000991) Gas panel - Venous blood

339

2015

1.77

19.64

9.5

9.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

235

1245

1.96

19.60

2.3

1.5

35.58

23.66

u/ml

0.81

229

1191

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

537

3614

1.59

19.30

3.1

2.7

21.80

22.80

0.94

506

3340

(3018095) Leukocytes [#/volume] in Urine

1227

9761

1.42

19.27

4.0

3.7

66.43

101.31

e6/l

0.98

895

6630

(36304419) Bacteria [Presence] in Urine

906

6818

1.46

19.20

3.2

2.9

7.62

365.89

estimate

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

2796

25975

1.72

19.17

21.2

12.3

82.64

81.71

ml/min/173m2

1.60

2662

23811

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

576

3955

1.56

18.94

2.2

1.8

—

(3026782) Osmolality of Urine

673

4783

1.52

18.89

2.8

511.14

518.82

mosm/kgh2o

0.41

595

4145

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

144

3.87

18.66

1.7

1.9

8.97

6.81

nmol/l

0.31

110

(3030467) Casts [#/volume] in Urine by Automated count

940

7157

1.45

18.62

3.3

3.0

0.36

0.39

e6/l

0.20

706

5178

(3019225) pH of Specimen

391

2454

1.68

18.56

9.1

3.6

7.37

7.35

0.86

352

1603

(3018677) aPTT in Platelet poor plasma by Coagulation assay

544

3706

1.57

18.47

2.8

2.0

29.43

29.42

0.02

529

3594

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

244

1336

1.90

18.44

9.5

10.4

24.47

24.37

mmol/l

0.21

238

1314

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

150

696

2.21

17.83

2.4

3.0

—

(3000850) Epithelial cells [#/volume] in Urine

779

5767

1.47

17.72

2.7

2.6

5.15

6.47

e6/l

2.08

708

5212

(3031040) Bacteria [#/volume] in Urine by Automated count

2030

17755

1.41

17.72

4.9

4.5

4062.15

1924.30

e6/l

0.36

224

(40768800) Prostate Pathology biopsy report

5.05

17.61

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

150

700

2.20

17.58

6.3

3.8

1.58

1.54

mg/l

0.22

140

630

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

378

2.64

17.50

1.4

1.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

194

1001

2.00

17.45

5.2

5.5

0.92

0.87

0.98

185

944

(3019060) Gas panel - Arterial blood

243

1356

1.86

17.30

4.6

5.3

—

(40761536) Microorganisms panel - Urine sediment

335

2062

1.70

17.05

4.1

3.8

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2319

20829

1.44

16.96

4.9

4.5

12.12

11.23

mm/h

2.16

2182

19567

(3022948) Iron [Moles/volume] in Serum or Plasma

611

4342

1.51

16.95

3.0

2.6

12.60

13.44

umol/l

2.17

582

4028

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

447

2969

1.59

16.82

2.1

1.7

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

570

3998

1.52

16.81

3.0

2.6

2.34

2.38

g/l

0.93

537

3686

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

422

2806

1.58

15.75

2.1

1.8

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

334

2111

1.65

15.33

9.6

7.9

1.23

1.33

mmol/l

1.19

329

2071

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

200

1095

1.88

15.11

5.2

1.63

1.61

0.11

191

1036

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1058

8519

1.37

14.28

2.9

2.4

55.78

58.96

u/l

0.63

980

7855

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

344

2232

1.61

14.17

1.2

137.55

136.98

u/ml

0.01

132

875

(3005719) IgG [Mass/volume] in Serum or Plasma

311

1976

1.64

13.95

3.6

2.5

10.19

10.67

g/l

0.90

288

1828

(3012544) pH of Venous blood

381

2543

1.57

13.91

5.7

3.7

7.38

0.26

227

1437

(3011412) CD3 cells [#/volume] in Blood

176

3.16

13.84

2.9

2.2

1206.94

1246.46

e6/l

0.12

153

(3002032) Base excess in Venous blood by calculation

369

2451

1.57

13.75

5.8

3.7

2.41

1.90

mmol/l

2.25

326

2176

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

247

2.79

13.70

1.2

120.82

111.56

pmol/l

0.21

247

(3020779) Urea [Moles/volume] in Serum or Plasma

319

2051

1.62

13.63

10.0

7.8

9.44

9.64

mmol/l

0.20

296

1968

(3022145) Colonoscopy Study observation

428

2955

1.52

13.38

1.4

1.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

790

6138

1.38

13.09

5.1

4.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

5.47

13.05

3.1

2.1

1.32

0.80

1.03

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2995

28796

1.96

12.91

28.3

16.7

75.83

73.80

umol/l

2.24

2982

28440

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

882

6990

1.36

12.88

2.5

2.4

2.82

2.70

mg/l

0.81

771

6077

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

4.46

12.83

1.2

12.73

12.20

pmol/l

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

114

545

2.13

12.65

2.0

1.4

—

(3004809) Band form neutrophils/Leukocytes in Blood

253

2.68

12.57

3.8

2.4

2.68

1.02

1.40

213

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

131

3.39

12.46

2.6

2.1

—

(3037756) Immunofixation for Serum or Plasma

401

2.31

12.32

1.8

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

5.51

12.11

1.6

1.8

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

132

678

1.99

12.08

1.8

1.4

14.01

10.65

u/l

1.26

550

(3026008) Bacteria identified in Urine by Culture

1018

8314

1.33

12.01

3.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

367

2508

1.52

11.98

5.9

3.7

5.95

5.83

kpa

1.46

356

2448

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

147

790

1.90

11.79

2.4

1.8

12.07

1.82

ug/l

0.53

130

690

(3035715) Granulocytes [#/volume] in Blood

411

2.25

11.64

3.1

3.4

3.88

3.98

e9/l

0.17

411

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

282

2.52

11.56

3.1

2.2

340.78

27.62

u/ml

0.50

251

(3028626) Oxygen [Partial pressure] in Capillary blood

119

599

2.03

11.54

3.8

4.3

8.40

8.30

kpa

0.28

119

586

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

196

2.84

11.53

1.2

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

234

1458

1.65

11.32

2.4

2.3

11.26

13.75

nmol/l

3.98

213

1338

(3002179) Metamyelocytes/Leukocytes in Blood

317

2125

1.55

11.29

4.3

4.1

1.27

0.47

2.02

105

424

(3017181) Myelocytes/Leukocytes in Blood

328

2219

1.53

11.20

4.6

4.2

1.35

0.58

4.00

108

436

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

260

2.53

10.91

1.8

1.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1099

9169

1.31

10.88

3.9

2.8

28.39

34.69

u/l

2.34

1041

8624

(3035933) Granulocytes/Leukocytes in Blood

104

511

2.07

10.79

3.1

58.48

57.55

0.30

104

511

(3041096) Erythrocytes [Presence] in Urine by Automated

968

7956

1.31

10.64

3.5

3.2

0.07

0.25

estimate

0.54

342

2319

(3021901) Oxygen saturation in Capillary blood

468

2.11

10.56

3.3

90.76

89.94

0.55

455

(3000060) B lymphocytes [#/volume] in Blood

4.49

10.48

3.3

2.0

0.25

0.17

e9/l

0.40

(3027273) Bicarbonate [Moles/volume] in Venous blood

186

1114

1.71

10.45

3.4

3.1

26.07

25.45

mmol/l

1.57

178

1072

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

121

3.25

10.39

1.5

—

(3012501) Base excess in Blood by calculation

438

2.13

10.38

5.1

3.9

2.46

2.51

mmol/l

0.06

284

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

111

567

1.99

10.37

2.0

1.3

—

(1616796) Gas panel - Central venous blood

485

2.08

10.36

4.8

3.9

—

(3028026) IgM [Mass/volume] in Serum or Plasma

240

1543

1.60

10.24

2.4

1.5

1.26

1.27

g/l

0.02

222

1432

(3021440) Promyelocytes/Leukocytes in Blood

315

2155

1.51

10.20

4.6

4.3

0.19

0.05

1.44

373

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

259

1699

1.57

10.14

1.7

1.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

115

600

1.95

10.12

2.0

1.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

409

2956

1.44

10.03

2.9

2.2

7.33

6.60

umol/l

0.26

359

2541

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.47

10.01

1.3

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

242

1576

1.58

9.78

1.6

1.4

30.00

27.86

iu/l

0.44

201

1380

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

520

3942

1.38

9.68

3.1

2.8

3.41

3.38

e6/l

0.02

244

1827

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

347

2.22

9.54

2.2

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

289

1969

1.52

9.53

3.1

1.6

66.22

67.15

g/l

1.25

272

1785

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

144

2.94

9.50

1.5

—

(3042631) Mycobacterium sp identified in Specimen

254

2.43

9.45

3.4

3.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1551

13681

1.27

9.42

3.6

3.1

115.92

100.25

ug/l

1.96

1460

12848

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

169

1017

1.70

9.35

2.2

2.1

9434.17

5388.84

u/l

0.44

424

(3004119) Hemoglobin [Mass/volume] in Venous blood

242

1595

1.56

9.29

5.3

3.1

127.01

130.91

g/l

1.89

233

1544

(3025159) Blasts/Leukocytes in Blood

316

2206

1.48

9.26

4.7

4.5

0.13

0.01

1.86

358

(3009261) Glucose [Presence] in Urine by Test strip

1679

14976

1.26

9.17

4.1

3.9

0.01

estimate

0.10

392

2815

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

127

3.02

9.00

3.4

2.1

243.33

205.58

e6/l

0.55

107

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

416

2.07

8.97

1.8

1.4

0.33

0.41

nmol/l

0.55

339

(40768806) Pleura Pathology biopsy report

122

3.06

8.96

1.5

—

(3027945) Reticulocytes/Erythrocytes in Blood

357

2572

1.44

8.87

3.6

2.2

1.77

1.79

0.14

329

2271

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

269

2.33

8.80

1.8

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

129

2.97

8.76

3.4

2.0

488.55

448.93

e6/l

0.22

103

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

119

662

1.83

8.65

3.6

1.5

5.59

1.45

ratio

0.73

373

(3023520) Reticulocytes [#/volume] in Blood

281

1946

1.49

8.57

3.3

2.1

70.12

70.74

e9/l

0.09

204

1409

(3007853) Bacteria identified in Skin by Aerobe culture

410

3046

1.40

8.56

1.7

1.8

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

567

4445

1.34

8.42

3.0

2.7

0.84

1.22

e6/l

1.87

289

2340

(3006245) CD3-CD19+ cells/cells in Blood

3.57

8.39

3.2

2.0

13.45

9.61

0.66

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

+∞

8.33

1.3

0.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

+∞

8.33

1.0

0.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

519

1.92

8.31

1.6

1.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

643

5150

1.31

8.20

4.3

3.8

95.45

416.91

ng/l

7.14

480

3790

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

130

758

1.75

8.10

3.8

1.5

32.65

32.20

mg/l

0.05

108

635

(3034860) Kappa light chains.free [Mass/volume] in Serum

130

760

1.74

8.02

3.8

1.5

43.42

40.61

mg/l

0.27

108

641

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

421

2.00

7.99

4.8

5.6

1146.45

330.07

iu/ml

0.57

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

155

2.67

7.80

2.0

1.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

110

619

1.81

7.74

2.5

3.9

0.31

0.37

iu/ml

1.24

348

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.54

7.69

1.4

1.1

53.61

0.71

umol/24h

0.50

(3028308) Erythrocytes [#/volume] in Pleural fluid

162

2.61

7.69

1.5

24391.29

85765.71

e6/l

0.78

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2025

18643

1.24

7.61

3.5

3.2

43.92

41.44

u/l

0.87

1901

17513

(3023199) Leukocytes [#/volume] in Pleural fluid

188

2.47

7.49

1.5

2802.12

2333.46

e6/l

0.11

136

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

277

2.19

7.41

1.2

78.20

57.08

u/l

0.89

239

(3021601) Nitrite [Presence] in Urine by Test strip

1633

14716

1.23

7.40

4.1

3.8

0.00

estimate

0.41

400

2903

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

426

1.95

7.40

1.6

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

115

2.89

7.32

1.9

1.3

—

(3045788) Cell count panel - Pleural fluid

161

2.57

7.26

1.6

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

661

5399

1.28

7.17

1.5

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

1647

14902

1.22

7.01

4.1

3.9

6.26

3.80

estimate

0.22

411

2994

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

184

1218

1.54

6.97

1.9

2.0

38.47

39.77

u/l

0.38

164

1085

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

494

1.85

6.90

1.5

1.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1273

11234

1.22

6.90

4.0

3.8

1.45

0.13

estimate

0.45

351

2374

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1158

10121

1.23

6.89

3.8

3.6

41.81

60.18

ng/l

0.70

775

6609

(3012441) Differential panel - Pleural fluid

154

2.55

6.85

1.7

1.5

—

(3008295) Osmolality of Serum or Plasma

281

2.12

6.77

1.4

1.5

283.31

277.53

mosm/kgh2o

1.01

215

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

111

653

1.73

6.76

3.6

2.6

3.50

3.58

g/l

0.21

103

612

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

121

2.75

6.69

1.9

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

128

2.67

6.57

1.9

1.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

273

1991

1.41

6.34

3.7

3.1

171.08

175.17

ng/l

0.06

249

1807

(3004588) Protein electrophoresis panel - Serum or Plasma

233

1655

1.44

6.27

2.7

1.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

483

1.80

6.17

1.6

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

340

1.96

6.16

1.7

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

111

672

1.68

6.12

3.5

3.2

1.67

1.75

index

0.06

335

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

118

727

1.65

6.08

2.2

11.41

11.39

mg/l

0.01

110

674

(21494814) CD8 cells/Lymphocytes in Specimen

3.20

5.86

1.6

2.2

33.77

24.03

2.37

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

282

2096

1.38

5.86

3.4

2.4

65.21

68.87

ml/min/173m2

0.88

138

849

(21494434) Karyotype in Bone marrow

102

2.76

5.79

1.2

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

449

1.80

5.77

1.7

1.3

—

(3010503) CD19 cells [#/volume] in Blood

108

2.70

5.75

2.6

2.3

91.59

141.65

e6/l

1.54

103

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

2.80

5.72

2.9

2.6

41.81

48.67

1.34

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

732

6202

1.24

5.65

2.1

1.8

1.12

1.04

mg/l

0.21

567

4721

(4281824) Cell count and differential, peritoneal fluid

164

2.33

5.58

1.1

—

(3049717) Cytology report of Urine Cyto stain

108

672

1.63

5.40

2.5

1.8

—

(3001019) Free T4 and TSH panel - Serum or Plasma

219

1586

1.41

5.33

2.2

1.7

—

(3000012) Reticulocyte production index

267

2.00

5.32

2.4

1.6

1.01

0.89

0.48

155

(3017732) Neutrophils [#/volume] in Blood

439

3528

1.28

5.32

3.1

2.8

4.00

4.52

e9/l

2.01

395

3051

(40768441) Liver Pathology biopsy report

149

2.36

5.31

1.0

1.5

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

996

8754

1.20

5.25

2.4

2.2

173.78

208.18

u/l

0.68

963

8251

(40768797) Stomach Pathology biopsy report

481

3917

1.27

5.23

1.3

1.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

130

852

1.55

5.23

2.9

3.1

24.96

25.02

mmol/l

0.07

130

838

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

434

1.77

5.21

1.4

1.5

129.25

151.53

au/ml

0.65

137

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2934

28612

1.41

5.12

15.2

10.3

24.93

25.33

u/l

0.72

2876

27718

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

149

1011

1.50

5.11

2.0

1.6

1.58

1.54

g/l

0.19

128

876

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

222

1630

1.39

5.00

4.5

4.1

5.10

5.19

kpa

0.99

217

1560

(3017354) Segmented neutrophils/Leukocytes in Blood

179

2.19

5.00

3.8

2.5

56.46

58.46

0.18

145

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

6.89

4.95

5.6

1.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

702

5998

1.22

4.92

1.7

1.4

2.33

2.37

g/l

0.14

467

3623

(3009343) pH of Capillary blood

215

1577

1.39

4.87

4.5

4.1

7.42

7.41

1.62

188

1307

(3048929) Epstein Barr virus Ab [Presence] in Serum

125

830

1.53

4.77

1.4

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

195

1413

1.41

4.75

2.3

2.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

158

2.23

4.68

1.7

1.5

6.39

7.62

u/l

0.23

128

(3008757) Leukocyte morphology finding [Identifier] in Blood

171

2.18

4.68

6.0

2.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

876

7678

1.20

4.66

3.1

3.2

1423.28

1116.05

ng/l

0.75

748

6539

(3021387) Prolactin [Units/volume] in Serum or Plasma

144

994

1.47

4.57

2.2

1.7

326.48

293.68

mu/l

0.54

134

894

(3032352) Blasts [#/volume] in Cerebral spinal fluid

8.20

4.56

1.7

1.1

—

(3017704) Immunofixation for Urine

122

2.39

4.56

1.5

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

4.53

4.55

1.4

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

366

2933

1.28

4.53

1.8

1.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

314

2470

1.30

4.49

2.7

2.3

31.18

57.47

u/l

0.73

265

2061

(44806118) Parainfluenza type 4 nucleic acid detection

299

1.85

4.47

1.5

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

299

1.85

4.47

1.5

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

299

1.85

4.47

1.5

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

299

1.85

4.47

1.5

1.4

—

(3007461) Platelets [#/volume] in Blood

3011

29562

1.50

4.46

33.6

20.1

258.36

256.11

e9/l

1.19

2972

28956

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

110

722

1.54

4.45

2.9

2.4

181.82

180.10

0.07

104

679

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

4.39

4.43

1.1

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

449

1.69

4.41

1.5

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

3011

29566

1.50

4.41

33.4

20.0

90.22

90.91

16.69

2995

29243

(3035941) MCH [Entitic mass]

3011

29567

1.50

4.40

33.4

20.0

30.00

30.25

14.92

2995

29244

(3002079) Sodium [Moles/time] in 24 hour Urine

137

2.28

4.38

1.2

1.3

152.27

161.39

mmol/24h

0.26

137

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

3011

29569

1.50

4.37

34.3

20.5

40.35

40.74

1.03

2994

29232

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

478

3969

1.24

4.37

1.8

1.6

—

(3026361) Erythrocytes [#/volume] in Blood

3011

29571

1.50

4.35

33.5

20.1

4.52

4.50

e12/l

1.35

2965

28861

(3010813) Leukocytes [#/volume] in Blood

3011

29572

1.49

4.34

33.6

20.1

6.57

6.62

e9/l

0.47

2967

28851

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.89

4.33

1.4

2.9

0.62

mmol/l

0.04

(3000963) Hemoglobin [Mass/volume] in Blood

3011

29579

1.49

4.25

33.8

20.2

134.61

135.50

g/l

3.09

2995

29257

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

188

1382

1.38

4.24

4.4

4.0

2.48

1.80

mmol/l

1.80

150

1032

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

4.13

4.20

1.5

1.1

29.41

1.77

umol/24h

0.52

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

164

1188

1.40

4.05

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

362

1.73

4.02

1.3

1.2

17.70

20.48

u/l

0.30

310

(46235355) HIV 1 and 2 tests - Meaningful Use set

561

4791

1.21

3.89

2.0

1.9

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

677

5883

1.19

3.89

1.7

453.67

48705414.13

pmol/l

6.73

544

4942

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

106

714

1.50

3.85

1.3

1.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

256

1.85

3.85

3.8

2.0

0.85

1.51

g/24h

1.29

133

(3026493) Urate [Moles/volume] in Serum or Plasma

795

7014

1.18

3.82

2.8

2.2

332.84

332.00

umol/l

0.08

709

6160

(3015736) pH of Urine

1289

11807

1.16

3.81

3.6

3.4

6.19

6.24

0.75

737

6619

(40765096) Chromosome analysis panel by Banding

3.95

3.79

1.2

1.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

3.70

3.79

1.6

1.2

145.91

88.52

ng/l

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

6.68

3.67

1.6

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

489

1.59

3.65

1.8

1.6

0.74

0.78

g/l

0.12

385

(3036489) Thrombin time

133

948

1.42

3.63

2.5

2.0

20.98

20.53

0.46

118

822

(3003181) Sodium [Moles/volume] in Urine

498

1.58

3.62

1.4

64.67

61.56

mmol/l

0.24

405

(3029937) Albumin [Presence] in Urine by Test strip

900

8069

1.16

3.49

4.2

4.0

0.00

estimate

1.28

370

2770

(3030981) Hyaline casts [#/volume] in Urine by Automated count

263

2094

1.28

3.46

2.5

2.3

0.20

0.32

e6/l

2.27

251

1985

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

166

2.00

3.44

2.1

1.5

—

(3016750) Collection duration of Urine

126

2.15

3.41

1.7

2.2

497.11

503.45

min

0.16

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

3.52

3.40

2.8

2.2

0.30

0.14

nmol/l

0.75

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

370

3075

1.23

3.36

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

101

2.29

3.35

5.7

5.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

141

2.07

3.31

1.4

1.8

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

518

1.54

3.30

1.4

1.3

288.65

255.56

u/ml

0.46

307

(3047189) Immunofixation for 24 hour Urine

2.62

3.30

2.4

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

266

2136

1.27

3.28

6.5

3.2

4.86

4.59

kpa

0.99

257

2081

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

173

1313

1.34

3.25

5.8

2.9

0.63

0.61

0.24

173

1307

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

301

1.71

3.25

1.6

1.2

2.32

2.89

ug/l

0.48

267

(21494890) Protein electrophoresis panel - 24 hour Urine

184

1.91

3.24

1.9

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.68

3.22

1.1

1.3

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

5.34

3.19

7.1

1.7

—

(3037522) Nuclear Ab [Titer] in Serum

508

4379

1.19

3.17

1.4

422.86

566.07

titre

1.39

105

969

(3006184) Hemoglobin [Mass/volume] in Capillary blood

605

1.48

3.15

2.6

2.3

126.70

131.09

g/l

0.82

478

(3023419) Bacteria identified in Sputum by Culture

336

1.65

3.10

3.6

2.8

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

641

1.46

3.08

1.4

1.3

34.65

30.28

e6/l

0.09

481

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

276

3367

0.80

3.07

5.1

32.72

32.66

0.03

184

2255

(3021879) Hepatitis B virus core Ab [Presence] in Serum

235

1880

1.27

3.01

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

653

1.45

3.00

1.4

1.3

880.02

887.66

e6/l

0.00

521

(3009508) Creatinine [Moles/volume] in Urine

1080

9900

1.14

2.97

3.5

7.19

7.29

mmol/l

0.33

926

8416

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1331

12368

1.13

2.96

2.1

1.9

1.35

mmol/l

0.14

1113

10467

(3014051) Protein [Presence] in Urine by Test strip

894

8097

1.15

2.94

3.1

2.9

0.25

0.05

0.58

198

(3021960) Folate [Moles/volume] in Serum or Plasma

872

7889

1.15

2.91

1.7

21.55

20.73

nmol/l

0.34

769

6642

(3004451) EKG impression Narrative

143

1.97

2.84

1.3

—

(3037121) Protein [Mass/volume] in Urine

112

817

1.38

2.76

4.9

3.2

188.78

339.88

mg/l

2.56

287

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

104

2.12

2.74

1.0

1.2

119.41

111.52

0.74

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

256

1.69

2.71

1.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

311

1.62

2.67

1.7

1.4

2.75

2.82

g/l

0.08

225

(3024139) IgG subclass 3 [Mass/volume] in Serum

311

1.62

2.67

1.7

1.4

0.35

0.37

g/l

0.28

225

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

168

1.85

2.67

1.1

—

(4062490) Immunoglobulin typing, IgG

304

1.62

2.65

1.7

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

312

1.61

2.64

1.7

1.4

6.87

6.76

g/l

0.08

225

(3000570) Elastase.pancreatic [Mass/mass] in Stool

112

824

1.37

2.63

1.4

319.67

306.18

ug/g

0.28

465

(3026389) Candida sp identified in Specimen by Organism specific culture

416

1.53

2.62

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

134

1.95

2.60

1.5

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

605

5382

1.15

2.54

6.0

4.0

2.32

1.83

ug/l

1.60

544

4874

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

269

1.64

2.53

1.2

—

(40768443) Skin Pathology biopsy report

144

1110

1.31

2.50

1.3

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

270

1.64

2.50

2.6

2.4

31.49

38.10

iu/ml

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

439

1.49

2.45

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

439

1.49

2.45

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

130

1.93

2.45

1.5

1.3

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

6.26

2.37

11.8

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

596

5324

1.15

2.36

1.4

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1836

17530

1.11

2.34

3.3

3.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

175

1407

1.26

2.22

1.8

1.6

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

5.56

2.21

1.0

1.1

1.42

1.34

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

104

782

1.34

2.18

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

226

1.64

2.17

2.3

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

290

1.56

2.14

1.3

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

237

1983

1.21

2.09

1.3

67.73

49.90

au/ml

0.51

123

(3030313) Adrenal Ab [Titer] in Serum

4.01

2.04

1.0

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

779

7150

1.12

1.99

1.3

1.82

1.64

u/ml

0.20

224

1981

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

178

1.69

1.98

2.6

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

178

1.69

1.98

2.6

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

178

1.69

1.98

2.6

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

126

1.83

1.98

1.5

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.29

1.97

3.2

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

461

1.42

1.97

1.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

129

1017

1.28

1.96

2.2

1.4

4.25

4.26

g/l

0.04

121

908

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

202

1.64

1.95

2.4

1.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

129

1018

1.28

1.94

2.2

1.4

7.22

7.46

g/l

0.94

121

910

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

129

1018

1.28

1.94

2.2

1.4

3.65

3.71

g/l

0.22

120

910

(3000494) Fungus identified in Specimen by Culture

387

3401

1.16

1.94

1.7

1.5

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.97

1.93

1.8

1.5

—

(3020393) Adenovirus Ag [Presence] in Stool

2.73

1.93

1.6

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

105

809

1.31

1.90

1.2

80.00

92.60

titre

0.38

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

482

4310

1.14

1.89

4.6

3.7

22.23

24.10

1.91

254

1890

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.13

1.81

1.3

1.5

—

(3045414) Leukocytes [Presence] in Urine

233

2733

0.84

1.80

2.2

2.0

0.00

0.01

estimate

1.06

570

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.92

1.80

3.1

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.92

1.80

3.1

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.92

1.80

3.1

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.92

1.80

3.1

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1147

0.76

1.78

1.4

1.5

—

(3025941) Bacteria identified in Stool by Culture

184

1529

1.22

1.78

1.3

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

118

933

1.28

1.78

1.6

1.8

0.25

0.23

g/l

1.73

110

881

(3004775) Volume in Urine collected for unspecified duration

177

1.64

1.76

1.8

2.4

644.00

631.73

0.04

121

(3015171) Extractable nuclear Ab [Units/volume] in Serum

157

1286

1.23

1.75

1.3

2.25

0.88

u/ml

0.31

111

(3044941) Cell count panel - Synovial fluid

515

1.37

1.75

1.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

110

1.82

1.72

10.9

7.1

56.08

62.21

mg/l

0.33

(3022475) Manganese [Moles/volume] in Blood

3.85

1.71

1.2

1.0

0.15

0.16

umol/l

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

251

2156

1.18

1.70

2.4

15.58

22.17

au/ml

1.12

228

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

203

1.58

1.68

2.4

2.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

112

889

1.27

1.65

2.2

1.4

10.24

10.22

g/l

0.01

103

775

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

277

1.49

1.64

1.2

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

756

0.72

1.62

1.4

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.58

1.61

3.6

1.9

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

356

3157

1.14

1.60

3.3

2.8

0.74

0.71

ug/l

0.35

244

1945

(40758292) HTLV I+II Ab panel - Serum

2.70

1.58

2.0

1.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

119

958

1.25

1.58

1.6

1.8

1.20

1.19

g/l

0.07

111

900

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

2.20

1.57

2.3

2.4

6.62

7.72

mmol/l

—

(3048689) Calprotectin [Mass/mass] in Stool

440

3967

1.13

1.53

2.6

2.4

110.38

121.05

ug/g

0.43

357

3164

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

265

1.48

1.53

1.2

2.02

1.87

u/ml

0.03

155

(3008536) Aspergillus sp Ab [Presence] in Serum

2.60

1.51

4.0

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.60

1.51

1.3

2.2

4.57

4.93

ug/l

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

123

1.71

1.50

1.1

—

(3012516) Albumin [Mass/volume] in Urine

984

9263

1.09

1.48

3.6

3.5

60.22

38.29

mg/l

1.54

611

5683

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.44

1.48

1.4

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.44

1.48

1.4

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.44

1.48

1.4

1.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

118

960

1.24

1.45

2.2

1.4

2.74

2.89

g/l

1.13

110

852

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

763

1.27

1.44

1.3

1.2

29.73

45.95

u/ml

0.68

(21494755) Public health laboratory ask at order entry panel

228

2623

0.86

1.43

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.79

1.43

1.8

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.79

1.43

1.8

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

2.31

1.43

1.4

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

196

1.54

1.42

1.3

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

995

9386

1.09

1.42

4.4

4.1

10.72

9.12

mg/mmol

0.24

596

5657

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

141

1.64

1.41

1.2

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

128

1054

1.22

1.41

1.6

1.7

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

103

1.75

1.40

1.2

1.0

—

(3023183) Ammonium ion [Moles/volume] in Plasma

484

1.33

1.39

1.8

2.8

25.57

34.71

umol/l

3.64

448

(3044007) Cell count panel - Peritoneal fluid

2.08

1.38

1.7

2.7

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

119

1.69

1.37

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

653

1.28

1.36

1.3

1.2

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

0.00

1.34

0.0

1.8

—

1.30

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

702

1.26

1.30

1.1

—

(3019150) Specific gravity of Urine by Refractometry

715

6674

1.09

1.29

4.4

4.1

1.02

1.25

kg/l

0.50

497

4354

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

802

1.24

1.29

1.1

1.94

6.73

eliau/ml

1.99

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.78

1.28

7.8

3.6

—

(3022313) Gas panel - Capillary blood

135

1131

1.20

1.27

4.8

4.1

—

(3023410) Appearance of Cerebral spinal fluid

285

1.41

1.27

1.6

1.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.05

1.26

1.2

1.0

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.40

1.24

24.5

11.6

4.98

5.55

mmol/l

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1131

0.81

1.23

2.3

1.8

4.03

4.42

mg/l

0.15

835

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

131

1.61

1.23

1.3

1.2

10.90

8.79

mm/h

0.34

131

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.91

1.22

1.2

—

(3024471) HLA-A [Type]

1.91

1.22

1.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

460

1.31

1.22

1.3

1.2

1.74

3.39

u/ml

1.26

160

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

662

0.75

1.22

1.3

1.5

65.53

60.31

ug/l

0.26

542

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.72

1.21

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.80

1.21

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.75

1.19

1.3

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

171

0.52

1.17

1.4

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

165

1.52

1.17

1.0

1.1

1.24

1.12

u/l

0.32

(1002224) Polysomnography panel

168

1448

1.17

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

0.00

1.16

0.0

1.0

—

0.16

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

0.00

1.16

0.0

2.6

—

41.54

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

456

1.30

1.15

1.3

1.2

4.77

4.61

u/ml

0.03

191

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

735

1.23

1.12

1.8

1.4

0.04

0.00

g/l

0.44

673

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

151

1.53

1.11

1.3

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.26

1.10

1.1

1.2

6.20

5.85

mmol/l

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

557

1.26

1.10

1.9

2.2

0.95

0.82

nmol/l

0.84

468

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.38

1.09

1.0

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2691

26544

1.10

1.07

5.4

5.1

5.91

5.88

mmol/l

0.50

2525

24597

(3019309) Folate [Moles/volume] in Red Blood Cells

483

4470

1.10

1.07

1.8

1.7

1188.40

1158.19

nmol/l

0.29

388

3423

(3023420) DNA double strand Ab [Units/volume] in Serum

154

1332

1.16

1.05

1.6

1.9

10.44

7.05

iu/ml

0.47

323

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

301

0.66

1.04

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

106

1.61

1.02

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

581

1.24

1.02

2.6

2.3

123.47

100.82

ug/min

0.14

345

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1156

0.83

1.00

1.5

1.6

1060.49

1021.91

mu/l

0.11

949

(4146454) Self-monitoring of blood glucose

297

0.67

0.99

2.3

2.8

—

(3024932) HLA-DR beta [Type]

1.81

0.98

1.0

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.97

0.0

1.0

—

0.03

—

(3000330) Specific gravity of Urine by Test strip

118

1377

0.85

0.96

3.4

3.1

1.02

ratio

0.80

109

1240

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.96

0.0

1.0

—

0.00

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

214

2394

0.89

0.96

1.6

1.7

3.44

3.49

mmol/l

0.27

142

1652

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

714

1.21

0.95

1.8

1.4

0.00

g/l

-0.00

636

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.95

0.0

1.3

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

173

0.58

0.94

37.8

18.9

1150.20

1441.60

nmol/l

—

167

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

143

0.56

0.93

1.1

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

226

1.38

0.92

6.2

3.5

11.67

13.48

index

0.56

114

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

209

1.39

0.92

1.5

2.2

1.67

1.81

u/field

0.05

118

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

313

1.31

0.91

1.2

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

428

1.27

0.91

1.2

1.1

123.66

117.00

0.80

385

(3034092) Cytoplasmic Ig cells/cells in Blood

2.14

0.91

5.5

10.8

0.13

0.18

—

(40768446) Kidney Pathology biopsy report

102

1.57

0.90

1.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

101

857

1.18

0.90

1.4

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

421

1.26

0.89

1.1

2.02

2.90

eliau/ml

0.50

190

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

325

1.30

0.86

2.0

1.6

310.11

330.77

mu/l

0.32

256

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

167

0.60

0.85

24.6

14.2

692.40

8568.34

nmol/l

—

161

(3022621) pH of Urine by Test strip

254

2309

1.11

0.84

2.6

6.11

6.08

0.21

164

1535

(3032773) Endomysium IgG Ab [Titer] in Serum

302

1.30

0.81

1.0

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

114

988

1.16

0.81

1.4

1.3

14.15

43.06

u/ml

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

104

895

1.17

0.81

2.6

1.8

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

464

1.23

0.79

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

114

1.49

0.79

3.8

2.4

21.84

87.37

ug/l

0.48

105

(3048879) Bone marrow aspiration report

1.82

0.79

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.82

0.79

1.3

1.1

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

187

0.64

0.78

1.3

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

236

2149

1.11

0.78

1.3

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.77

0.0

1.0

—

1.63

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

101

871

1.16

0.77

2.5

1.4

0.83

0.32

g/l

0.52

748

(3017569) Oxygen content in Arterial blood

140

1.43

0.76

1.8

1.9

14.96

16.57

1.46

140

(36660697) Celiac disease serology panel - Serum

277

2545

1.10

0.76

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

115

1003

1.15

0.76

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

323

1.27

0.76

1.5

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.64

0.75

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

230

2097

1.10

0.74

1.3

102.38

202.43

u/ml

3.80

213

1952

(40761995) Spermatozoa Progressive [#/volume] in Semen

2.09

0.74

2.8

3.1

57.80

47.08

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

2.09

0.74

5.6

6.3

8.00

7.37

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

492

0.79

0.74

1.7

1.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

828

1.16

0.74

2.2

1.7

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.64

0.73

1.6

1.3

—

0.35

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

228

1.32

0.72

4.3

4.1

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

2.00

0.72

8.0

3.0

22.60

24.76

mg/l

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.00

0.72

2.2

1.6

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

176

1.37

0.72

1.6

1.5

77.58

77.10

umol/l

0.03

176

(3035320) C reactive protein [Mass/volume] in Body fluid

220

1.32

0.71

2.7

18.92

28.72

mg/l

1.29

152

(3014271) Vancomycin [Susceptibility]

109

1.47

0.70

2.6

2.8

—

(3017509) Phencyclidine [Presence] in Urine

1.92

0.70

1.2

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.71

0.70

5.9

8.4

11.63

10.25

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.55

0.69

2.3

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

299

3221

0.92

0.69

1.9

2.0

3.45

3.40

ratio

0.28

229

2466

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

136

1211

1.13

0.68

1.3

1.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.85

0.68

1.2

1.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1296

12602

1.05

0.66

2.2

2.1

97.36

97.69

pmol/l

0.08

676

6358

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.61

0.65

4.6

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.61

0.65

4.6

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.61

0.65

4.6

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

1.48

0.64

1.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.73

0.64

1.6

2.4

0.80

0.76

u/field

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2629

26026

1.06

0.63

6.7

6.3

39.01

mmol/mol

0.01

2486

24508

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

7.65

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

140

0.64

0.60

1.8

6.6

—

54.31

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

417

1.20

0.60

1.6

1.4

31.30

27.92

u/l

0.26

320

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

171

1559

1.10

0.59

1.9

1.8

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.54

0.59

1.3

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

109

969

1.13

0.59

1.7

1.5

0.42

0.17

iu/ml

0.27

169

(3006576) Bicarbonate [Moles/volume] in Blood

1.53

0.59

11.6

7.0

25.39

25.08

mmol/l

0.11

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

400

1.20

0.58

2.5

2.7

13.40

13.19

0.48

395

(4268621) Lupus anticoagulant assay

327

1.23

0.58

2.2

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

0.58

0.0

1.0

—

4.71

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

318

1.23

0.58

1.5

1.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

140

1.36

0.58

1.3

152.26

220.83

pmol/l

0.49

140

(3045424) Erythrocytes [Presence] in Urine

119

1327

0.89

0.58

2.2

2.0

0.00

0.57

estimate

0.51

450

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

319

1.23

0.57

1.5

1.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.67

0.56

1.0

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

203

1875

1.09

0.55

2.0

1.9

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

601

0.85

0.55

1.3

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

103

921

1.12

0.52

1.4

1.3

4.82

7.03

u/ml

0.38

133

(3006922) Hepatitis E virus Ab [Presence] in Serum

205

1.27

0.52

1.0

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

100

1.40

0.51

1.0

0.27

1.33

u/ml

0.64

100

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

280

0.78

0.50

1.3

1.4

1.47

1.42

nmol/l

0.09

254

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

290

3079

0.94

0.50

2.0

—

(3042733) HLA Ab [Presence] in Serum

1.43

0.49

5.0

4.9

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

102

917

1.12

0.49

1.4

1.3

1.68

6.36

u/ml

0.64

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

421

0.83

0.48

1.7

1.5

71.16

57.20

ug/l

1.00

421

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

261

2776

0.93

0.48

2.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.41

0.46

1.2

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

778

1.12

0.46

1.2

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

674

1.13

0.46

1.8

1.4

0.00

g/l

-0.00

635

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.43

0.46

1.0

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

760

1.12

0.45

1.5

1.4

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

187

0.75

0.45

1.1

0.29

1.15

u/ml

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

610

0.87

0.45

1.3

1.5

1.10

1.20

ratio

0.32

370

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

610

0.87

0.45

1.3

1.5

1.45

1.15

ratio

0.75

368

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

610

0.87

0.45

1.3

1.5

0.93

0.96

ratio

0.12

368

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

100

905

1.11

0.44

5.6

4.3

25.46

24.77

mmol/l

1.47

830

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.37

0.43

1.4

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

274

0.80

0.43

1.7

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

202

1.24

0.43

1.3

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

393

0.84

0.43

1.2

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.43

0.42

1.1

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

276

1.20

0.42

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.40

0.42

1.3

1.6

1.20

1.17

mmol/l

—

(4195642) Thrombophilia screening test

425

1.16

0.42

1.2

—

(3024263) Appearance of Synovial fluid

139

0.72

0.42

1.9

1.7

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.4

—

588.48

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.41

0.0

7.6

—

105.06

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.41

0.0

1.1

—

172.88

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.36

0.41

1.1

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.40

0.0

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

786

1.11

0.40

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

204

1.23

0.40

1.3

1.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

141

1.28

0.40

1.0

1.2

165.72

318.33

u/l

1.07

123

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.40

0.0

1.1

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.39

0.0

2.8

—

3.35

—

(3000475) Leukocytes [#/volume] in Synovial fluid

713

1.11

0.38

1.7

1.6

14291.67

10266.02

e6/l

0.46

506

(3034274) Bile acid [Moles/volume] in Serum --fasting

366

0.85

0.38

1.4

2.1

5.76

5.62

umol/l

0.03

260

(3003740) Influenza virus B Ag [Presence] in Specimen

524

1.13

0.37

1.2

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.35

0.37

1.4

2.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

306

3206

0.95

0.37

1.6

1.7

1.41

1.44

0.39

265

2855

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

299

1.17

0.37

1.6

2.3

33.14

22.50

mg/l

0.53

104

(3002523) Influenza virus A Ag [Presence] in Specimen

525

1.13

0.36

1.2

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

829

0.90

0.36

1.0

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

263

1.18

0.35

1.2

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

0.63

0.35

1.0

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

227

1.19

0.34

1.3

1.2

54.40

58.04

u/ml

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

255

1.18

0.34

1.9

1.5

29.48

34.46

0.34

157

(3029396) Erythrocyte agglutination [Presence] in Blood

1.33

0.33

1.2

3.7

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2334

23146

1.03

0.33

28.2

17.0

331.94

332.01

g/l

0.15

2325

23032

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

188

0.80

0.33

1.2

1.5

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.30

0.33

3.3

2.7

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

146

1.23

0.32

1.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

132

0.76

0.32

1.4

—

1075418.09

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

528

0.89

0.31

1.4

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

295

1.15

0.31

1.6

1.3

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

733

1.09

0.31

1.3

1.5

—

22.17

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

772

1.09

0.31

1.2

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

296

1.15

0.30

1.6

1.3

—

(3005033) Fetal Nuchal fold Thickness US

505

0.89

0.30

1.3

1.5

1.23

1.27

0.27

357

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

588

6034

0.97

0.28

1.4

1.3

32.64

30.72

iu/ml

0.09

176

1826

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

450

1.11

0.28

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

564

0.90

0.27

1.5

1.6

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

384

1.12

0.27

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

299

1.14

0.27

1.6

1.3

—

(3025130) Human papilloma virus identified in Specimen

499

1.10

0.27

1.7

1.8

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.68

0.26

1.2

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

520

1.10

0.26

1.0

1.1

0.88

1.88

u/ml

0.96

263

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.67

0.25

1.2

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.67

0.25

1.2

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

169

1.18

0.25

1.3

1.1

1.07

1.05

ratio

0.27

138

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

277

0.87

0.25

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.20

0.25

3.2

3.1

10.27

kpa

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.20

0.25

3.2

3.1

5.11

5.00

kpa

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2584

25971

0.97

0.25

4.3

1.30

1.28

mmol/l

1.31

2400

24096

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

518

0.91

0.25

1.1

29.89

19.87

au/ml

0.25

125

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

309

3196

0.96

0.24

7.7

6.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2710

27217

0.97

0.24

5.2

5.1

1.47

1.51

mmol/l

4.85

2542

25511

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

142

1.20

0.24

1.6

2.0

—

(3024869) Neuronal Ab [Presence] in Serum

1.28

0.23

1.0

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

515

0.91

0.23

1.3

1.5

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.25

0.22

1.0

1.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

0.74

0.22

1.1

1.3

16.31

17.37

umol/l

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

136

1428

0.95

0.22

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

409

0.90

0.21

1.0

1.1

0.13

0.26

u/ml

—

142

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.19

0.21

1.0

1.1

12.10

7.32

u/ml

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3034614) HLA Ag [Interpretation]

0.00

0.21

0.0

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

488

1.09

0.21

3.5

3.4

0.82

nmol/l

0.04

394

(3007463) Buprenorphine [Presence] in Urine

0.00

0.21

0.0

4.4

—

(3042951) Complement C1q Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

24.44

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

335

1.11

0.20

1.9

1.6

70.09

57.94

1.18

206

(3018333) Ribosomal P Ab [Presence] in Serum

261

0.88

0.20

1.2

1.1

—

(3007456) Orange IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.09

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.20

0.0

1.0

—

1.43

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

0.00

0.20

0.0

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

170

1632

1.04

0.20

1.0

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

221

1.13

0.20

1.3

1.6

0.66

1.26

promille

1.23

176

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

307

1.11

0.20

1.5

1.8

—

1648.00

—

(4198724) Urine methamphetamine measurement

1.21

0.19

2.6

2.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

212

1.13

0.19

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

260

0.88

0.19

1.5

1.4

218118.29

87092.89

e6/l

0.34

180

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

213

2203

0.96

0.19

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.13

0.18

2.3

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

784

1.06

0.18

1.6

2.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

892

1.06

0.18

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.19

0.18

5.9

8.0

4.93

4.96

kpa

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

331

0.91

0.17

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

427

1.08

0.16

1.2

1.1

1.33

2.67

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

298

0.91

0.16

1.2

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2727

27352

0.98

0.16

5.3

5.2

4.68

4.72

mmol/l

1.57

2575

25802

(3051387) C reactive protein [Mass/volume] in Capillary blood

565

0.94

0.15

2.6

3.6

38.43

24.33

mg/l

1.03

390

(3028433) Virus identified in Specimen by Culture

1.15

0.15

1.1

—

(3008898) HLA-B27 [Presence]

115

1104

1.04

0.15

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

286

0.91

0.15

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

286

0.91

0.15

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.79

0.14

1.0

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.78

0.14

1.1

1.6

7.26

9.28

ug/l

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

181

0.88

0.14

1.3

1.4

—

568.33

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

160

0.87

0.14

1.0

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

243

0.90

0.13

4.4

2.9

51.84

21.81

mg/l

0.58

169

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

0.82

0.13

3.0

2.7

34.95

29.13

umol/l

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

412

1.07

0.13

1.2

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

451

1.07

0.13

1.1

33.30

1424.60

iu/ml

—

(3027944) Amphetamines [Presence] in Urine

103

991

1.04

0.13

1.6

1.9

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

932

1.04

0.13

1.4

1.3

247.85

222.89

miu/ml

0.27

463

(44813793) Dust mix specific IgE antibody measurement

211

0.90

0.13

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

103

993

1.04

0.12

1.6

2.0

—

(3044927) Protein electrophoresis panel - Urine

268

1.08

0.12

1.2

1.1

—

(3000492) Spirometry study

277

2824

0.98

0.11

1.5

—

(4024509) Urine culture

142

1380

1.03

0.11

1.8

1.9

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

105

1.14

0.11

1.3

1.8

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

560

5666

0.99

0.10

1.4

1.3

11.39

11.32

u/ml

0.01

226

2278

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

115

1.13

0.10

1.7

2.4

—

(3016879) Cocaine [Presence] in Urine

919

1.03

0.10

1.5

2.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

496

1.05

0.10

1.2

—

(40757373) Influenza virus identified in Isolate

1.11

0.09

1.0

1.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

432

0.95

0.09

1.0

1.1

0.60

4.56

u/ml

5.24

190

(3051101) Glucose [Moles/volume] in Cord blood

1.04

0.09

6.0

7.1

9.28

8.19

mmol/l

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

122

1188

1.03

0.09

1.7

1.6

17.42

16.32

u/ml

0.07

279

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

268

0.93

0.09

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

380

1.05

0.09

1.8

2.0

—

7.50

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

288

0.94

0.08

1.2

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.07

0.08

1.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

115

1180

0.97

0.08

1.9

1.5

0.32

0.33

mg/l

0.09

518

(3011897) Casein IgE Ab [Units/volume] in Serum

0.82

0.08

1.2

0.01

1.13

u/ml

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

226

0.93

0.08

1.0

1.1

19.03

8.88

iu/ml

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.09

0.08

5.4

7.8

5.97

6.02

kpa

—

(3020874) Milk IgE Ab [Units/volume] in Serum

195

0.92

0.08

1.0

1.21

1.06

u/ml

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

756

1.03

0.08

1.4

1.3

15.01

3.55

u/ml

—

(3002619) Bacteria identified in Specimen by Culture

1.06

0.08

1.0

1.2

—

(3003129) Base excess in Capillary blood by calculation

297

0.94

0.08

2.5

2.1

0.81

0.85

mmol/l

0.02

284

(4034850) Laboratory test

915

1.03

0.07

12.9

9.3

—

(4211845) Urine protein measurement

137

1.10

0.07

2.1

3.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

540

0.96

0.07

1.3

1.2

—

(3027008) Opiates [Presence] in Urine

102

996

1.02

0.07

1.6

2.0

—

(3011288) Drugs identified in Urine by Screen method Nominal

701

0.97

0.07

1.7

2.7

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.12

0.06

1.8

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.12

0.06

1.8

1.3

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

167

1.08

0.06

1.3

1.2

0.57

0.55

ratio

—

102

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

216

1.07

0.06

1.0

287.83

355.61

ng/l

0.80

148

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.85

0.06

1.1

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

128

1.09

0.06

1.2

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1013

0.98

0.06

1.1

0.61

0.64

ratio

0.22

130

(3022689) Creatine [Moles/volume] in Urine

103

0.87

0.06

1.3

1.4

5.87

7.98

mmol/l

—

103

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

217

1.06

0.06

1.0

920.00

726.23

ng/l

0.73

141

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

119

1.09

0.06

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

216

2133

1.01

0.05

2.0

2.3

6.11

7.30

ug/l

0.38

185

1881

(3020650) Glucose [Presence] in Urine

1.11

0.05

1.5

1.8

0.00

0.07

estimate

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

792

1.02

0.05

1.2

1.1

4.92

3.86

—

106

(3028300) Cannabinoids [Presence] in Urine

102

1003

1.02

0.04

1.6

1.9

—

(1761482) Bacteria [#/volume] in Urine by Culture

576

1.02

0.04

3.7

4.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

200

0.95

0.03

1.1

21.39

15.91

u/ml

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

220

1.05

0.03

1.0

33.00

48.55

ng/l

1.14

148

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

667

1.02

0.03

1.0

1.1

1.41

2.25

u/ml

0.78

371

(3019832) Treponema pallidum Ab [Presence] in Serum

253

2547

0.99

0.03

1.8

1.7

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

241

1.04

0.02

1.3

1.4

8.00

8.56

mmol/l

0.28

232

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2767

27688

0.99

0.02

6.0

5.9

2.74

2.76

mmol/l

0.63

2602

26032

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

138

0.94

0.02

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

470

0.98

0.02

1.0

1.1

1.36

3.41

u/ml

1.86

233

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

108

1092

0.99

0.02

1.2

1.1

1.52

1.56

g/l

0.87

108

1092

(3039443) Prostate specific Ag panel - Serum or Plasma

329

0.97

0.02

1.3

1.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

441

1.02

0.02

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

461

1.02

0.02

2.0

1.7

—

(1761868) Lipid panel - Serum or Plasma

1117

11151

1.00

0.02

3.2

3.1

—

(3034426) Prothrombin time (PT)

103

1.07

0.02

1.2

28.00

28.24

0.04

103

(3006462) Nitrate [Presence] in Urine

123

1.06

0.01

2.2

3.3

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

163

1.04

0.01

1.1

1.0

0.24

2.54

u/ml

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

193

1.04

0.01

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

548

0.99

0.01

1.0

1.1

0.71

1.04

u/ml

0.30

245

(3028707) Methadone [Presence] in Urine by Screen method

427

0.98

0.01

1.9

2.6

—

(3006653) Thiamine [Moles/volume] in Blood

155

0.97

0.00

1.2

1.3

126.07

134.84

nmol/l

0.80

155

(3045683) HLA typing for celiac disease panel - Blood or Tissue

195

0.97

0.00

1.1

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

235

0.98

0.00

1.3

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

159

1.01

0.00

1.2

1.1

1943.25

1555.54

miu/ml

0.64

159

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

229

1.00

0.00

1.1

1.2

39.48

34.88

mg/l

0.12

192

(3044242) Glucose [Moles/volume] in Arterial blood

136

1.03

0.00

1.2

1.8

7.41

8.49

mmol/l

0.93

136

(3004616) Nuclear Ab [Presence] in Serum

394

0.99

0.00

1.5

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

562

1.00

0.00

1.1

3.99

4.28

u/ml

0.09

306

(3011397) Hemoglobin [Presence] in Urine by Test strip

685

6846

1.00

0.00

4.1

3.8

0.67

0.17

—

(44806420) Estimation of glomerular filtration rate

343

0.99

0.00

2.1

2.5

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

213

0.99

0.00

1.0

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.99

0.00

1.4

1.5

0.51

0.48

e9/l

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.00

0.00

1.2

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

29.06

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.88

-0.00

1.2

1.1

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

435.50

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

0.94

-0.00

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

2767.67

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

4.4

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.91

-0.00

1.0

1.2

123.49

47.47

u/ml

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3033099) Centromere Ab [Titer] in Serum

0.91

-0.00

1.0

1.2

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

8.8

—

(3033086) Enterovirus Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

5.8

—

0.24

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.4

—

155.20

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

305.00

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(4015189) Microbial culture of sputum

0.97

-0.00

4.8

2.5

—

(3017400) Magnesium [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

3.40

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

0.94

-0.00

1.8

1.9

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.87

-0.00

1.0

32.70

36.72

iu/ml

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

2.2

—

4.51

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

1228.00

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_ENDOCRINE – Malignant neoplasm of endocrine gland

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of endocrine gland

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints